EX-10.1 2 ea021857301ex10-1_founder.htm UNDERWRITING AGREEMENT DATED OCTOBER 22, 2024 BY AND BETWEEN THE COMPANY AND REPRESENTATIVE

展品10.1

 

創始人集團有限公司

 

承銷協議

 

2024年10月22日

 

美國虎牌證券公司。

麥迪遜大道 437 號,27th 地板

紐約州紐約市10022

 

代表承銷商

指定於 附表A 此處

 

女士們,先生們:

 

FOUNDER GROUP LIMITED,一家根據英屬維爾京群島法律設立的有限公司公司擬根據本合約規定的條款和條件,發行並賣出合計 1,218,750 普通股(該“實股”),無面值(該“普通股)給所列多家承銷商 附表A 此簽署方(「承銷商」)由美國虎證券有限公司代表(“USTS代表人)。公司還同意授予代表承銷商 擁有權(“超額配售選擇權”),根據本協議第1(b)部分的條款,購買多達182,813股普通股(“認購權股票”)和Firm股份一起,稱爲“股份”, 併發行此類股份的行爲以下簡稱爲“增發計劃。” 公司還同意向代表發行 代表權證(如第1(c)條所定義),連同權證基礎的普通股在此稱爲「warrants」代表證券。” 這些股份和代表的證券 在此統稱爲“證券.”

 

公司確認如下 與每位承銷商的協議:

 

1. 賣出協議與購買.

 

(a) 購買公司股份。 根據本協議中公司的陳述、擔保和協議,以及本協議的所有條款和條件,公司同意單獨而非共同出售公司股份給承銷商,承銷商同意單獨而非共同從公司購買公司股份,購買價格爲每股3.72美元(“每股15.50美元”) .

 

(b) 購買期權 股份。 根據本協議的所有條款和條件,公司代表承銷商授予了超額配售期權,可購買182,813股或更少數量的額外期權股份,相當於發行的認購股份的15%,價格與每一認購股份的分配購買價格相同。在行使超額配售期權之前,承銷商沒有購買任何期權股份的義務。超額配售期權可在截止日期後的任何時間全部或部分行使,並在行使日45天內以書面通知最後截止日期通知公司,說明要購買的期權股份總數以及期權股份的交付和支付時間和日期(“期權通知”),由代表向公司提出,在代表、代表律師或公司和代表協商同意的其他地點(包括遠程傳真或其他電子傳輸方式)辦公室。如果期權股份的交付和支付未在截止日期發生,期權截止日期將如期權通知中所列。一旦行使超額配售期權,公司將有義務轉讓給承銷商,且在本文所列條款和條件約束下,承銷商有義務購買期權通知中指定數量的期權股份。如果有任何期權股份需購買,每位承銷商同意分別而非聯合購買與其所購買的認購股份數量成比例的期權股份選擇權收盤日附表A在保險公司名稱相反。根據本協議,“第十章 轉讓證券 第10.1節 交易 如果發行受託人證明,債券持有人可以交換並迅速交付發行受託人這樣的證明,無論是有欠款未償還,還是實質性週轉的時候,都可以在世界範圍範圍內經由源和債券市場交易。” 表示除星期六、星期日或商業銀行在紐約市授權或法律規定必須閉館的其他日期;但是,如果銀行無法在指導任何政府當局的情況下關閉實體分行地點,而這些銀行的電子資金轉賬系統(包括電匯)在該日可供客戶使用,則不應視爲銀行被授權或有義務關閉。

 

 

 

 

(c) 代表的 認股權證。 公司特此同意於閉市日向代表(或其各自的指定人)發行認股權證,以購買在本次發行中發行的普通股總數的四個百分點(4%)(即“代表認購權證”。代表的認股權證可在公開證券銷售啓動之日起181天后的任何時間全部或部分行使,並於本次發行開售之日起三年週年日屆滿時到期,初始行使價格爲每股4.80美元,相當於此次交易結算日發行的股票初始公開發行價格的百分之一百二十(120%)。代表的認股權證和代表的認股權證行使後發行的普通股以下統稱爲“代表證券.”

 

2. 交付及支付.

 

(a) 結束。 通過存管信託公司(「Depository Trust Company」)的設施將公司股份交付給代表,“DTC以即時可用資金通過銀行電匯方式支付購買價格,支付給公司的訂單。此類支付應在東部時間上午10:00進行,根據《證券交易法》第15c6-1(a)條規定,在此協議簽訂後的第二個營業日進行支付(如果發行價格在東部時間下午4:30後確定,應根據《證券交易法》第15c6-1(c)條規定,在交易所法》第15c6-1(c)條規定,在此協議簽訂後第三個營業日),或者在公司和代表商定的最遲不遲於該日後的十個營業日內進行,而不遲於此日期。該日期以下簡稱爲“結束日期。”).

 

(b) 期權結束。 在適用程度內,超額配售選擇權被行使時,按照上文指定的方式和地點,期權股份的交付將於期權通知中所指定的日期和時間進行,該日期和時間可能爲結束日期,但不得早於結束日期。

 

(c) 電子轉賬。 在購買時,股票的電子轉賬應以代表指定的名稱和麪額進行。

 

(d) 稅票。 公司發行和交付證券時,如有任何原始發行稅票費用,應由公司承擔。公司應支付並承擔每位承銷商和任何隨後持有證券的持有人與原始發行、出售及交付給該承銷商的證券相關的、由於未能或延遲支付美國聯邦和州以及外國的印花稅和其他轉讓稅(如有的話)而產生的任何和所有責任。

 

2

 

 

3. 公司的陳述和保證公司向每位承銷商聲明並保證,並作出以下承諾:

 

(a) 遵守註冊要求。 根據1933年修訂的《證券法案》(以下簡稱爲「證券法案」)的規定,公司已根據要求準備了關於股票的F-1表格(註冊編號333-281167),包括初步招股書以及本協議簽署日期前可能需要的任何修訂,該註冊聲明及其任何修訂(統稱爲「註冊聲明」) 已提交給委員會。公司已向承銷商提供了該註冊聲明及其任何修訂,包括相關的初步招股說明書。術語“行動”)和相關規則和法規(統稱爲“規則和法規美國證券交易委員會(「委員會」) 委員會:”),並已向委員會提交。公司曾向委員會提供有關先前提交的註冊聲明及每項修訂件(如果有的話)的副本,包括相關的初步招股說明書。術語“蘋果公司CEO庫克大規模拋售股票,套現逾3億港元,資金已存入上市公司設立的專項帳戶(「信託帳戶」),以公共股東(定義詳見下文)爲受益人的註冊聲明(FORM S-1)中所規定的一定金額及特定款項。信託帳戶中持有的基金類型(包括資金持有的利息)除支付公司稅費以外,一旦實現以下最早的情況之一即可支取: (i) 完成首次(業務)組合;(ii) 如果公司未能在2025年3月3日之前完成首次(業務)組合,則可以贖回100%的發行股份(如下所述);或 (iii) 股東表決贖回發行股份。 若要批准修訂本Amended and Restated Certificate,必須就修訂對決定最早如下情形之一的公司的義務以在首次業務組合中允許贖回或未在終止日期之前完成首次業務組合即贖回100%的發行股份產生影響或涉及股東權益或首次業務組合前的活動(如第9.7節所述),對修訂進行表決。發售期(「發售期」)所出售單位的組成部分的Common Stock股份的持有人(「發售股份」),不論這些發售股份是在發售期內還是在發售市場上的二級市場中購買,也不論這些持有人是公司的發起人,高管或董事,或上述任何關聯方的子公司,均在此被稱爲「公共股東」。「申報表」 是指在生效時或已生效時按照F-1表格修訂的註冊申報表,包括基本報表、所有附件和任何被視爲包含或參照其中的信息,包括根據Rule 430A或規則和法規中的規定視爲包含的任何信息。如果公司提交一份註冊申報表來註冊一部分股份,並依靠《規則和法規》中的規則462(b)使該註冊申報表在提交給委員會時生效(「公司」提及的任何「註冊申報表」都應被視爲包括規則462註冊申報表,且應不時修訂)。第462號註冊聲明),則任何提及「註冊申報表」的應被視爲包括規則462註冊申報表,且應不時修訂)。本處所指“「註冊申報表」指根據Rule 430或Rule 430A規則和法規設計的初步招股說明書,隨時作爲或被視爲註冊申報表的一部分或包含在其中。初步招股書「招股說明書」 指根據《規則和法規》第430條或第430A條考慮到的與本次發行有關的最終招股說明書,其首次依據《規則和規定》第424(b)條向委員會提交,或者如果不需要進行此類申報,則指註冊申報表生效日期的最終招股說明書形式,唯獨,如果公司向代表提供了用於與股份有關的招股說明書有所不同的修訂招股說明書或招股說明書補充材料(無論是否要求公司根據Rule 424(b)提交此類修訂招股說明書或招股說明書補充材料),則在此之後,「招股說明書」一詞還將稱呼此類修訂招股說明書或招股說明書補充材料(視情形而定)。招股書任何本處提及與「註冊申報表」、任何初步招股說明書或招股說明書有關的「修改」、「修訂」或「補充」一詞應被視爲幷包括:(i)依據1934年修訂的證券交易法案的任何文件提交,並與在下文規定的規則和法規一起(簡稱「法案」)使擁有公司註冊證券類別10%以上股權的官員、董事或實際股東代表簽署人遞交表格3、4和5(包括修正版及有關聯合遞交協議),符合證券交易法案第16(a)條及其下屬規則規定的要求;在註冊聲明的生效日期之後,即其所附的初步招股說明書或招股說明書的日期,以及(ii)任何已提交的文件。

 

(b) 註冊的有效性。 註冊聲明,任何規則462註冊聲明和任何後續修正已被委員會根據法案宣佈生效或根據《規則與法規》的第462條生效。公司已回應委員會對額外或補充信息的所有請求,如果有的話。沒有暫停生效註冊聲明或任何規則462註冊聲明的止損市價單正在生效,沒有爲此目的而啓動或正在進行的程序,或者據公司所知,委員會沒有威脅到這個。

 

(c) 註冊的準確性 聲明。 每份註冊聲明、任何第 462 條註冊聲明及其任何生效後的修正案,均位於 生效時間、根據《交易法》提交的任何文件何時提交或已經提交以及以後的所有時間都得到遵守和將來 在所有重要方面遵守該法和細則和條例,過去和將來都不會包含任何不真實的陳述 重要事實或省略陳述必須在其中陳述或爲在其中作出陳述所必需的重大事實 誤導性。經修訂或補充的招股說明書自其發佈之日起以及招股說明書交付或需要時的所有後續時間 (或者,如果不符合第172條的規定,則必須交付)與證券銷售相關的交付, 遵守並將將在所有重大方面遵守該法、《交易法》和《規則和條例》,但沒有或不會 包含對重大事實的任何不真實陳述,或省略陳述使其中陳述不產生誤導性所必需的重大事實, 鑑於它們是在什麼情況下製造的.無需向委員會提交任何相關文件 在此考慮的交易中,(x) 尚未按照《證券法》的要求提交,或 (y) 將不會提交 在規定的時間內。初步招股說明書中無需描述合同或其他文件,或 招股說明書,或作爲註冊聲明的證物或附表提交(”重大合同”),其中 尚未按要求進行描述或提交。每份初步招股說明書(包括初步招股說明書或提交的招股說明書) 作爲註冊聲明(或其任何修正案的一部分),交易所在提交該法的所有重要方面均符合該法的要求 法案和規章制度,以及每份初步招股說明書和招股說明書交給代表以供相關使用 本次發行的內容與向委員會提交給EDGAR的電子傳輸副本相同,但以下情況除外 由 S-t 法規允許。本第 3 (c) 節中的上述陳述和保證不適用於任何陳述或遺漏 依據承銷商以書面形式向公司提供的與承銷商有關的信息,並符合承銷商的相關信息 通過代表,專門用於納入註冊聲明或招股說明書或其任何修正或補充。 出於本協議的所有目的,”承銷商信息” 應指向公司提供的書面信息 由該承銷商通過代表明確供其使用;據理解並同意,唯一的此類信息 由任何承銷商提供的承銷商的姓名和地址均包括初步招股說明書中披露的承銷商的姓名和地址,註冊表 聲明或招股說明書。

 

(d) 公司不符合資格發行人在提交與證券相關的註冊聲明時;以及在簽署並交付本協議的日期(以該日期作爲本條款(ii)目的確定日期),公司不是「不合格發行人」(根據規則和法規第405號規則定義)。

 

3

 

 

(e) 銷售時披露。 截至適用時間,無論(i)發行人在適用時間或之前發行的普通使用自由書面意見書(如下定義),與本次發行相關的最新初步招股說明書 及其中包含的信息 附表 II 此處,所有板塊綜合考慮在一起(統稱爲“一般披露文件),也不能(ii)將任何個別發行人有限使用自由書面意見書與普通披露文件一起考慮,就其在製作時的情況而言,該等文件中的任何陳述,或遺漏陳述任何必要的重大事實爲使該等陳述不具有誤導性。前述句子不適用於普通披露文件中的聲明或遺漏,其根據並符合承銷商通過代表向公司提供的書面信息而進行,雙方理解並同意,承銷商提供的唯一信息包括承銷商信息。

 

在本小節中使用 以及本協議的其他地方:

 

適用時間“下午4點(紐約時間)2024年10月22日或公司和代表另行同意的其他時間。

 

發行人免費書面說明書「」表示《規則和法規》第433條規定的「發行人自由書面招股說明書」,涉及(i)需由本公司向委員會備案的股份,(ii)在規則433(d)(8)(i)的意義上屬於「路演」的書面通信,無論它是否需要向委員會備案,或者(iii)根據規則433(d)(5)(i)免於備案,因爲它包含未反映最終條款的證券或發行的描述,在每種情況下以提交或需提交給委員會備案的形式,如果不需要備案,則以公司記錄根據規則433(g)保留的形式。

 

發行人一般使用 自由書面招股說明書” 表示任何發行人自由書面招股說明書,旨在向潛在投資者進行普通分發, 正如其在文件中的特定指定 附表I 現有信貸協議第10.14條的規定已經納入本協議並適用於本協議。

 

發行者有限使用 自由撰寫招股說明書「」表示任何不是發行人一般使用的自由書面招股說明書的發行人自由書面招股說明書。

 

(f) 發行人免費書面招股說明書。 每份發行人免費書面招股說明書,在其發佈日期以及在後續的招股說明書遞交期(如下定義)期間,不包含與註冊聲明所含信息相沖突的任何信息。上述內容不適用於根據與承銷商信息一致的信息所涉及的發行人免費書面招股說明書中的陳述或遺漏。如果在發行發行人免費書面招股說明書後的任何時間發生了事件或情況,導致該發行人免費書面招股說明書與註冊聲明中相關證券的信息發生衝突,包含虛假陳述或遺漏了必要以使其陳述不誤導的重大事實,公司已迅速通知代表並已迅速自行費用修訂或補充該發行人免費書面招股說明書以消除或糾正此衝突、虛假陳述或遺漏。

 

(g) 公司發佈的發售材料分發。 在收盤日期之前,公司未分發並將不會分發任何與股份發行或銷售、註冊聲明、初步招股說明書、代表審查並同意的幷包含在此處的允許的自由撰寫招股說明書以及招股說明書相關的發售資料。在其各自發布日期直至招股說明書交付期(如下文所定義)結束時,任何市場營銷材料均不包含與註冊聲明中的信息衝突的信息。如果在任何市場營銷材料發佈之後發生了一項事件或發展,導致該市場營銷材料與有關證券的註冊聲明中的信息衝突或包含一個事實性錯誤陳述或遺漏了一個在該隨後時間當前的情況下有必要闡明的重大事實,使得其陳述不會誤導,公司將立即通知代表並迅速自行支付費用修正或補充該市場營銷材料以消除或糾正這種衝突、錯誤陳述或遺漏。 附表I 公司董事長未發佈,且在收盤日期之前不會發布任何有關股份發售或銷售、註冊聲明、初步招股說明書、代表審查並同意的幷包含在此處的允許的自由撰寫招股說明書以及招股說明書。截至其各自發布日期及在招股說明書交付期(如下文所定義)結束時,任何市場營銷材料均不包含與註冊聲明中的信息衝突的信息。如果在發佈任何市場營銷材料後的任何時間發生了一項事件或發展,導致該市場營銷材料與有關證券的註冊聲明中的信息發生衝突,或包含一個事實上的錯誤陳述或遺漏了一個在該隨後時間當前的情況下有必要闡明的重大事實,使得其陳述不會誤導,公司將立即通知代表並迅速自行支付費用修正或補充該市場營銷材料以消除或糾正這種衝突、錯誤陳述或遺漏。

 

4

 

 

(h) 子公司所有直接和間接的子公司(以下簡稱爲"公司")均列於註冊聲明書、一般披露文件和招股說明書中。公司直接或間接擁有每個子公司的股份或其他股權,不受任何抵押、債務、質押、安全利益、擔保權、優先購買權或其他類似限制的限制。已發行的每個子公司的股份全部屬實發行,已全部支付,不需要追加,並且沒有優先購買和類似購買證券的權利,已發行的每個子公司的股份全部屬實發行。「財政部條例」是指根據《稅收法典》頒佈的所有擬議、臨時和最終條例,這些條例可能會不時修訂(包括後續條例的相應規定)。所有直接和間接的子公司(以下簡稱爲"公司")均列於註冊聲明書、一般披露文件和招股說明書中。公司直接或間接擁有每個子公司的股份或其他股權,不受任何抵押、債務、質押、安全利益、擔保權、優先購買權或其他類似限制的限制。已發行的每個子公司的股份全部屬實發行,已全部支付,不需要追加,並且沒有優先購買和類似購買證券的權利,已發行的每個子公司的股份全部屬實發行。擔保機構所有直接和間接的子公司(以下簡稱爲"公司")均列於註冊聲明書、一般披露文件和招股說明書中。公司直接或間接擁有每個子公司的股份或其他股權,不受任何抵押、債務、質押、安全利益、擔保權、優先購買權或其他類似限制的限制。已發行的每個子公司的股份全部屬實發行,已全部支付,不需要追加,並且沒有優先購買和類似購買證券的權利,已發行的每個子公司的股份全部屬實發行。

 

(i) 組織和資格。 公司和每家子公司是一個正式註冊或以其他方式組建的實體,有效存在且信譽良好 根據其公司或組織管轄權的法律,擁有擁有和使用其財產的必要權力和權力 和資產,並按目前的方式開展業務。公司和任何子公司均未違反或違約 其各自的證書或公司章程、章程或其他組織或章程文件中的任何條款。 公司和子公司均具有開展業務的正式資格,並且在每個司法管轄區都信譽良好 所經營業務的性質或其擁有的財產的性質使得此類資格成爲必要,除非不符合資格 或信譽良好 (視情況而定) 不會產生或合理預期會導致:(一) 對合法性產生重大不利影響, 本協議、承保人認股權證或任何其他協議、文件、證書或文書的有效性或可執行性 必須根據本協議交付(統稱爲”交易文件”),(ii) 重大不利因素 對經營業績、資產、業務、一般事務、管理、股東權益、前景或狀況的影響 從整體上看,公司及其子公司的(財務或其他方面),或(iii)對公司的重大不利影響 能夠在任何重要方面及時履行其在任何交易文件下的義務((i)、(ii) 或 (iii) 中的任何一項), 一個”重大不利影響”),沒有訴訟、索賠、訴訟或訴訟(包括但不限於部分程序, 例如沉積),(每個,一個”正在進行中”) 已在任何此類司法管轄區提起訴訟或威脅撤銷, 限制或削減或試圖撤銷、限制或限制此類權力和權限或資格。

 

(j) 授權; 執行公司具有必要的法人權力和授權,以簽訂並完成本協議及其他交易文件所 contemplat 的交易,以及履行其在本協議和其他文件下的義務。 公司簽署並交付本協議及其他交易文件,並根據公司的所有必要行動及董事會和公司股東就此事項或其他事項的授權,無需進行額外行動。除了與所述的必要批准事宜相關聯外。 3(l)章節。本協議及其它交易文件均已(或在交付時將被)由公司妥善簽署,根據此協議和相關條款的規定交付後,只要代表合法授權、簽署和交付,即構成公司對公司有約束力的有效和具有約束力義務,除非(i)受普適的一般公平原則和影響債權人的權利執行的適用破產、破產、重組、停止支付和其他普適性法律的限制,(ii)受到涉及具體履行、禁令救濟或其他補救措施的可用性法律的限制,和(iii)在適用法律下對擔保和貢獻條款的限制可能。

 

(k) 沒有衝突除非在登記聲明中披露,公司根據本協議及其他交易文件履行、送達和執行,證券的發行和銷售以及根據本協議和其他文件的交易的完成不會且不會(i)與違反公司或任何子公司章程、公司章程或其他組織或憲章文件的任何規定衝突或違反,或(ii)與公司或任何子公司的任何財產或資產上產生任何留置權,或者給予他人任何終止、修改、加速或取消的權利(無論是否通知、時間流逝或兩者兼有)的任何協議、信貸安排、債務或其他文件(證明公司或子公司的債務或其他情況)發生違約(或在通知或時間流逝或兩者兼有下會發生違約)或者使公司或任何子公司有任何財產或資產以及(iii)根據必需批准,與或會違反公司或子公司受制於法律、規定、規則、命令、判決、禁令或其它任何法院或政府機構的限制(包括聯邦和州證券法律和法規)的任何法律,或者使公司或子公司的任何財產或資產所受約束或影響;在款(ii)和(iii)的情況下,如果會導致或合理預期會導致重大不利影響則除外。

 

5

 

 

(l) 申報、同意 和批准。公司無需獲得任何同意、豁免、授權或命令,也無需向其發出任何通知或作出任何通知 向任何法院或其他聯邦、州、地方或其他政府機構或其他個人申報或註冊 公司執行、交付和履行交易文件,但不包括:(i) 向委員會提交交易文件 註冊聲明和招股說明書,(ii)向納斯達克股票市場有限責任公司申請普通股上市 (iii) 按要求的時間和方式在納斯達克資本市場上進行交易,(iii) 必要的申報(如果有) 應根據適用的州證券法作出,(iv) 必須獲得或作出的通知、申報或授權 根據金融業監管局的適用規定(”FINRA”)已由代表提交, 以及 (v) 截至本文發佈之日獲得、發出或作出的通知、文件或授權(統稱爲”必填項 批准”).

 

(m) 證券發行。 公司股份、代表持股的選擇權股和根據相關交易文件行使代表權證後發行的普通股已得到充分授權,且在按照適用交易文件支付發行後,將被充分和有效地發行,已足額支付且無須進一步徵稅,且沒有公司強加的任何留置權。公司已經從其充分授權的註冊資本中保留了根據本協議可發行的最大數量的普通股。

 

(n) 資本化 截至本日,公司的資本構成如註冊聲明書、通用披露包和招股書所述。公司未發行任何資本股份,除非根據就業協議、諮詢協議、公司的股權激勵計劃發行,以及根據公司或附屬公司的證券轉換和/或行使,可能使持有人隨時可獲取普通股的任何債務、優先股、權利、期權、認股權證或其他工具,包括但不限於能夠轉換爲、行使或交換爲或者使持有人隨時有權收到普通股的任何工具。「普通股等價物」指的是,統稱爲期權和可轉換證券以及公司或子公司發行的任何其他證券,其持有人在任何時間都有權購買普通股,包括但不限於任何債務、優先股、權利、選擇權、認股權或其他工具,該工具在任何時間都可以轉換成、行使或交換爲普通股,或者以其他方式使持有人有權接收普通股。)截至最近已提交的對註冊聲明書的修訂日期,均有效且尚未償還。沒有任何個人或公司、合夥企業、信託、合併或未合併的協會、合資企業、有限責任公司、股份有限公司、政府(或政府機構或隸屬部門)或其他任何種類的實體(以下簡稱“"持有”)擁有對交易文件中約定的交易的優先購買權、優先購買權、參與權或類似權利,或參與其中的類似權利。除非經已購買和出售證券或如在註冊聲明書、通用披露包和招股書中披露的,公司沒有任何未行使的期權、認股權證、認購權、訂立的任何種類、與任何持有人有關的任何性質的承諾,或該等證券、權利或債務可轉換爲或行使或交換成的,或授予任何個人任何訂閱或取得的權利普通股或任何附屬公司的資本股份,或公司或任何子公司已訂立的合同、承諾、諒解或安排,按照條款公司或任何子公司有義務發行額外的普通股或普通股等價物或任何子公司的資本股份。發行和銷售證券將不會要求公司或任何子公司向任何個人(除承銷商外)發行普通股或其他證券,並且不會導致任何公司證券持有人按照這些證券的行權、轉換、交換或重新設定價格調整的權利。未經在註冊聲明書、通用披露包和招股書中披露或因證券拆股並股、資本重組等而披露,公司或任何子公司沒有任何股權或類似調整權利(除了股票拆股並股、資本重組等的調整)的證券,或具有任何交換權利或重新設定權利的證券。除了在註冊聲明書、通用披露包和招股書中披露的內容外,公司或任何子公司沒有任何包含任何贖回或類似條款的證券或工具,也沒有公司或任何子公司必須贖回公司或該等子公司的證券的合同、承諾、諒解或安排。除了在註冊聲明書、通用披露包和招股書中披露的內容外,公司沒有任何股權增值權或「幻影股票」計劃或協議或任何類似計劃或協議。所有公司的已發行股份均經過充分授權、有效發行、全部已付清及免除額外徵稅,一直遵守聯邦和州的所有證券法,符合註冊聲明書、通用披露包和招股書對其描述的情況,沒有發行的股份違反任何優先購買權或類似權利或者購買證券的權利。不需要任何股東、董事會或其他人員的進一步批准或授權來發行和銷售證券。不存在針對公司資本股的股東協議、表決協議或其他類似協議,公司是其一方,或根據公司盡到問詢義務後的最佳了解是公司的股東之間或公司的股東之間的協議。

 

6

 

 

(o) 重大變化;未公開事件、負債或發展自最新審計財務報表中包含的日期起,(i)沒有發生或預期會產生重大不利影響的事件、情況或發展,(ii)公司 或任何子公司 沒有承擔任何重大負債(有擔保或無擔保),除了(A)與過去慣例一致在經營過程中發生的應付賬款和應計費用,以及(B)根據國際財務報告準則不需要在公司財務報表中反映或在提交給委員會的文件中披露的負債,(iii)公司未更改其會計方法,(iv)公司未宣佈或支付任何現金股息或分配其他財產給股東或購買、贖回或簽署購買或贖回任何公司股本的協議,並且(v)公司未向任何董事、董事或以任何可能直接或間接通過一個或多箇中介人控制或被控制或與公司實行共同控制的人發行任何股本證券(如證券法規則405項下的術語所用和理解)(每個人稱爲“附屬公司”),除了根據現有公司股權激勵計劃或在註冊聲明、一般披露文件和招股說明書中規定的情況。公司未向委員會申請保密信息處理。除本協議擬議的證券發行外,就公司或其子公司或其各自業務、財產、經營、資產或財務狀況而言,在此聲明或視爲作出聲明時在適用證券法項下公司需要披露的並且在本協議簽署日期前尚未公開披露的情況、責任、事實、情況或發生或存在的事件或發展。

 

(p) 訴訟。那裏 沒有待處理的行動、訴訟、調查、違規通知或訴訟程序,或者在經過適當調查後,據公司所知,沒有受到威脅 在任何法院、仲裁員面前或由任何法院、仲裁員以書面形式針對或影響公司、任何子公司或其各自的財產, 政府或行政機構或監管機構(聯邦、州、縣、地方或外國)(統稱爲”行動”) (i) 對任何交易文件或證券的合法性、有效性或可執行性產生不利影響或質疑 或者 (ii) 如果作出不利的決定,將產生重大不利影響。除註冊聲明中披露的內容外, 一般披露一攬子計劃和招股說明書,既不是公司也不是任何子公司,也不是其任何董事或高級管理人員,是 已成爲任何涉及違反聯邦或州證券法或州證券法的索賠或索賠的訴訟的主題 違反信託義務。尚未有待處理或受到威脅,據公司所知,經過適當調查,沒有待處理或受到威脅 委員會以書面形式進行的任何涉及公司或本公司任何現任或前任董事或高級職員的調查。至 據公司所知,委員會沒有發佈任何停止令或其他暫停任何註冊生效的命令 公司或任何子公司根據《交易法》或《證券法》提交的聲明。據公司所知,之後 經過適當調查,公司的董事和執行官不是任何法律、政府或監管程序的當事方 (i) 將導致該董事或高級管理人員不適合擔任其在董事會或公司的職位(視情況而定) 可能會,(ii)會單獨或總體上產生重大不利影響,或(iii)必須在註冊中描述 聲明、一般披露一攬子計劃和最終招股說明書,但未如此描述。

 

(q) 勞工關係公司認爲與員工關係良好,並且據公司所知,公司或其任何子公司的員工之間不存在勞資糾紛。無論是公司還是子公司的員工,都不是與公司或該子公司之間關係有關的工會成員,而且公司或其任何子公司都不是集體談判協議的當事方。在充分了解的情況下,據公司最好的了解,公司或其任何子公司的高級主管,現在或預計將來,都不違反任何就業合同、保密、披露或專有信息協議、競爭禁止協議,或任何其他合同或協議,或任何人對第三方有利的限制性條款,且繼續僱傭每位高級主管不會使公司或其任何子公司對任何上述事項承擔法律責任。公司及其子公司符合所有適用於就業和就業慣例、就業條款和工資和小時的法律法規,以及其註冊地的法域和當前經營業務的地點的法規,除非不遵守不會單獨或合計對公司造成重大不利影響。

 

7

 

 

(r) 合規性除非在註冊聲明、一般披露文件和招股說明書中披露,否則公司或任何子公司: (i)未違約或違反(並且沒有發生任何未被豁免的事件,帶有通知、時間或兩者結合的情況下,會導致公司或任何子公司違約的情況),公司或任何子公司未收到書面終止通知或違約或違反任何主要合同、債券、貸款或信貸協議或任何其他協議或文書的聲明,任何一方都不是該協議的當事方或其財產,其財產所約束(無論是否免除了該違約或違反),(ii)違反任何法院、仲裁員或其他政府部門的判決、法令或令到(iii)任何法規的違反,包括但不限於涉及稅收、環境保護、職業健康與安全、產品質量與安全和僱傭勞動事宜的所有外國、聯邦、州和地方法律,除非一般有利息影響。

 

(s) 環保母基公司及其子公司(i)在所有實質方面遵守所有聯邦、州、地方和外國法律,涉及環境污染或保護人類健康或環境(包括大氣、地表水、地下水、地表或地下地層),包括與化學品、污染物、污染物、有害物質或廢物的排放、排放、釋放或有威脅的釋放有關的法律(統稱爲「化學品」);(二)已獲得依照適用的環境法律要求的所有許可證或批准;和(三)在所有許可證、許可證或批准的所有條款和條件下符合,一旦不遵守將會有單獨或總體上產生重大不利影響。危險物質)進入環境或與危險物質的製造、加工、分銷、使用、處理、儲存、處置、運輸或處理有關等不違反聯邦、州、地方和外國的所有有關污染、保護人類健康或環境(包括環境空氣、地表水、地下水、陸地表面或地下層)的法律,包括與化學藥品、污染物、污染物、有毒或危險物質或廢物(統稱爲「化學品」)的排放、排放、釋放或威脅有關的法律,以及在該等法律範圍內頒發、簽發或批准的所有授權、代碼、法令、要求或需要信、禁令、判決、許可證、通知或通知信、命令、計劃或法規,以及在該等法律範圍內頒發、簽發、批准或批准的所有授權、代碼、法令、要求或要求信、禁令、判決、許可證、通知或通知信、命令、計劃或法規。環保母基每家公司的主要環境法律問題塊包括但不限於以下範疇:公司和其子公司(i)在所有實質方面遵守所有聯邦、州、地方和外國法律,涉及環境污染或保護人類健康或環境(包括大氣、地表水、地下水、地表或地下地層),包括與化學品、污染物、污染物、有害物質或廢物的排放、排放、釋放或有威脅的釋放有關的法律(統稱爲「用於污染」);(二)已獲得依照適用的環境法律要求的所有許可證或批准;並且(iii)符合所有這些許可證、許可證或批准的所有條款和條件,其中在每個條款(i)、(ii)和(iii)中,未能如此遵守將會單獨或總體上產生重大不利影響。

 

(t) 監管許可證公司及其子公司持有,並且嚴格遵守所有證書、授權和許可證,這些證書、授權和許可證均由適當的聯邦、州、地方或外國監管機構頒發,以便按照註冊聲明中描述的各自業務進行,除非沒有持有這些許可證將導致重大不利影響("材料許可證),公司或任何子公司未收到任何有關撤銷或修改任何重大許可證相關程序的書面通知。所有重大許可證均有效並且具有充分的效力,並且不包含任何未在註冊聲明、總體披露文件和招股說明書中描述的實質性負擔性限制或條件。公司或任何子公司沒有任何理由相信這些重大許可證不會按照正常程序續期。

 

(u) 資產所有權公司及其子公司對其擁有的全部不動產擁有良好和市場上可出售的所有權,並且對其擁有的對公司及其子公司業務重要的全部動產擁有良好和市場上可出售的所有權,且這些所有權沒有任何留置權負擔,除非在註冊聲明書、一般披露文件和招股說明書中另有披露。

 

(v) 知識產權根據公司的最佳了解,在進行過妥善調查後,公司及其子公司擁有使用與註冊聲明中描述的各自業務相關的專利、商標、服務標誌、商號、商業祕密、發明、版權、許可和其他知識產權及類似權利的權利,如未具備該權利將個別或總體上產生重大不利影響。根據公司的最佳了解,在進行過妥善調查後,公司或任何子公司沒有收到任何聲明的書面通知,或者對任何人的知識中沒有公司或任何子公司違反或侵犯知識產權的情況。公司沒有知識表明其將無法取得可能對其業務進行必要的任何知識產權。

  

(w) 保險公司及其子公司已通過具有認可的財務責任的保險公司投保,以應對此類損失和風險,並採取了在公司和子公司從事的業務中明智和習慣的措施,包括但不限於董事和高級職員保險覆蓋範圍。公司和任何子公司均無理由相信其無法在現有保險覆蓋到期時續保或從相似的保險公司獲取類似的保險覆蓋範圍,以便繼續業務而不會顯著增加成本。

 

8

 

 

(x) 與關聯方和僱員發生的交易。 除註冊聲明中所述外,公司的董事或董事會成員,以及公司或任何子公司的員工,按照公司盡職調查後的最佳了解,目前沒有與公司或任何子公司進行任何交易(除了作爲員工、董事或董事會成員提供的服務),包括任何合同、協議或其他安排,涉及向公司或由公司提供服務、出租房地產或個人財產、借款或貸款或要求向公司的任何董事、董事或員工支付的其他方式,以及公司根據盡職調查後的最佳了解任何董事、董事 或這樣的僱員擔任的任何實體,其中包括直系家庭成員,其所擁有的股權超過(i)12萬美元或 公司過去兩個已完成財政年度年末資產總額的平均值的百分之一; 除了(i)支付工資或提供的諮詢費用服務,(ii)對代表公司發生的費用進行報銷,以及(iii)其他員工福利,包括公司任何股票期權計劃項下的股票期權協議。

 

(y) 薩班斯-奧克斯利; 內部會計控制作爲一家新興增長企業和較小的報告公司,公司及其子公司在必要的範圍內,完全符合截至本協議簽署日期有效和適用於公司的《2002年薩班斯-奧克斯利法案》的所有適用要求,截至本協議簽署日期有效的所有適用美國證券交易委員會制定的規則和法規,以及截至收盤日期或選擇性收盤日期有效的所有適用規則和法規。公司及其子公司建立了一套內部會計控制體系(根據《證券交易法》第13a-15和第15d-15條規定)足以提供充分的合理保證,確保:(i)交易按照管理層的一般或具體授權進行,(ii)交易記錄是必要的,以便按照國際財務報告準則編制財務報表,並保持資產責任歸屬,(iii)資產僅在符合管理層一般或具體授權的情況下進行訪問,(iv)記錄的資產責任與合理間隔時段內的現有資產進行比較,並針對任何差異采取適當措施。公司及其子公司已建立了公司和子公司的披露控制和程序(根據《證券交易法》第13a-15(e)和第15d-15(e)條規定),並設計了這些披露控制和程序,以確保公司在根據證券交易法提交的報告中需要披露的信息被記錄、處理、歸納和報告, 這些信息必須在委員會規則和表格規定的時間內進行。除了在註冊聲明、一般披露文件和招股說明書中所述的情況外,公司不知道其財務報告內部控制存在任何重大弱點。公司未收到董事會口頭或書面通知,陳述董事會正在審查或調查,也沒有公司獨立核數師或內部核數師建議董事會審查或調查:(i)添加、刪除、更改公司的重要會計政策的應用,或更改公司與之相關的披露,(ii)可能導致公司在當前或前兩個財政年度任何年度或中間期間的財務報表重述的任何事宜。

 

(z) 某些費用;FINRA 隸屬關係。除非註冊聲明、一般披露一攬子計劃和招股說明書中另有規定,否則不得進行經紀或 發現者的費用或佣金是或將由公司或任何子公司支付給任何經紀商、財務顧問或顧問, 與交易文件所設想的交易有關的發現者、配售代理人、投資銀行家、銀行或其他人員。 據公司所知,除代表外,沒有其他安排、協議或諒解 本公司或據公司所知,任何可能影響承銷商薪酬的股東,如 由 FINRA 決定。公司沒有向 (i) 任何人直接或間接付款(現金、證券或其他形式),因爲 發現費、投資費或其他費用,以該人爲公司籌集資金或介紹公司作爲對價 向公司提供資金的公司人員,(ii)任何FINRA成員,或(iii)任何有直接或間接資金的個人或實體 在註冊聲明發布之日之前的12個月內與任何FINRA成員的隸屬關係或聯繫 向委員會提交(”申報日期”) 或之後。據公司所知,沒有 (i) 高級管理人員或董事 本公司或其子公司的,(ii) 本公司或其子公司未註冊證券10%或以上的所有者 或(iii)在申請日之前的180天內收購的任何數量的公司未註冊證券的所有者, 與任何 FINRA 成員有任何直接或間接的隸屬關係或關聯。公司將向承銷商及其各自提供建議 如果得知公司或其子公司的任何高管、董事或股東是或成爲關聯公司,則爲其提供法律顧問;或 參與本次發行的FINRA成員的關聯人士。

 

9

 

 

(dd)投資公司公司不是,不會是,也不會在收到股票款後,或是成爲或成爲《1940年投資公司法案》修改後的「投資公司」的關聯公司。

 

(bb) 子計劃是指經董事會或委員會通過,旨在允許或促進向根據任何非美國司法管轄區的法律組建、或在美國以外、或在美國以外司法管轄區組建的某些指定子公司的僱員發佈獎勵的任何子計劃,每個這樣的子計劃均旨在符合該外國司法管轄區的適用法律。儘管爲了符合適用法律,任何子計劃都可以被指定爲從計劃中分離且獨立的計劃,但計劃股票儲備和計劃第4條中指定的其他限制條款將總體適用於計劃和任何此處通過的子計劃。註冊權益除了註冊聲明、一般披露文件和招股說明書所規定的事項外,任何人都無權要求公司或任何子公司根據證券法註冊公司或任何子公司的任何證券。

 

(cc) 掛牌和維護 要求普通股根據《交易法》第12(b)條進行註冊,公司未採取任何旨在終止普通股在《交易所法》下注冊的行動,也未收到任何書面通知稱委員會正在考慮終止該註冊。根據代表提供的信息,普通股目前可通過託管信託公司或其他建立的結算機構進行電子轉移,公司目前按時支付給託管信託公司(或其他建立的結算機構)的相關費用以進行電子轉移。根據公司的了解和盡職調查,本次證券的發行和銷售不違反納斯達克股票市場的規章制度。

 

(ee) 本公司不會直接或間接地將募集所得用於借出、貸出、爲任何子公司或任何合併關聯實體、合資企業夥伴或任何其他個人提供保證,資助或其他方式提供資助(e) 據公司所知,Assentsure PAC(「公司」)。 無論是公司還是代表公司採取行動的任何人,也無論是公司經過適當調查後其所了解的任何聯屬公司,均未直接或間接地就任何安全性做出任何要約或銷售,或就買入任何安全性進行任何徵求意見,且旨在導致股東提案的股東批准規定與納斯達克股票市場適用的任何成員所作出的先前發售相結合的情況下供應本次股票的。

 

(gg) 遵守薩班斯·奧克斯利法案2002年的合規性。除公司、其子公司和合並關聯實體外,據公司所知,任何公司董事、高級職員、僱員或聯繫人,任何授權代表公司行事的其他人,均沒有直接或間接、知情或者不知情地向薩班斯·奧克斯利法案的任何規定的接收方支付或承諾支付任何錢款、禮品或者類似的好處(在日常商業中向客戶提供合法的價格優惠除外),特別是向其顧客、供應商、顧客或供應商的代理人或在國內或外國的任何政府機構或儀器、政治黨派或候選人或爲公司的業務提供幫助或妨礙的人或其他任何可能使公司在民事、刑事或政府訴訟或程序中遭受任何損失或罰款的人支付任何費用。償付能力根據公司的合併財務狀況截止日期及期權截止日期的情況,在考慮到公司從出售股份中收到的款項以及公司當前現金流量的情況下,加上公司將收到的款項,如果公司清算其所有資產後,考慮到現金的所有預期使用情況,將足以支付所有應於要求支付時支付的債務。公司不打算不負擔其能力範圍內的債務,以便償還債務到期時的借款時間和金額(考慮到債務到期時應支付的現金的時間和金額)。除註冊聲明、一般披露套件和招股說明書中載明的情況外,公司不知曉任何事實或情況使其相信將在關閉日期或期權截止日期之一年內根據任何司法管轄區的破產或重整法申請重整或清算。在本協議的目的上,“負債”表示(x)除了在業務常規過程中產生的應付賬款超過50000美元以外,所有借款或欠款的債務(y)所有擔保、背書和其他擔保債務的義務,不管這些義務是否反映在公司的合併資產負債表(或附註)中,除了因在業務常規過程中背書擔保可轉讓票據的按金,用於存款或收款或其他類似交易;以及(z)根據國際財務報告準則要求進行資本化的租賃下應支付的超過50000美元的現值。除註冊聲明、一般披露套件和招股說明書中所載的情況外,公司或任何子公司均無違約涉及任何債務的情況。

 

10

 

 

(ff) 涉外腐敗行爲法。公司、其子公司和合並關聯實體及據公司所知的公司的任何董事、高級職員、僱員或附屬公司或管理公司授權執行業務的任何其他人,均沒有直接或間接地向任何客戶、供應商、員工或客戶或供應商的代理人或政府機構或政治黨派或任何政府(國內或國外)或候選人或在業務中可能幫助或阻礙公司(或就任何實際或擬議交易協助公司)的任何人支付或同意支付任何金錢、禮品或類似的好處,不包括在日常商業上向客戶提供合法的價格優惠,這可能會使公司在民事、刑事或政府訴訟或程序中承擔任何損害或罰款。稅收狀況除了不會在單獨或合計上產生重大不利影響的事項外,公司及其子公司均已提交或申報了所有美國、英屬維爾京群島和馬來西亞聯邦、州和地方所得稅以及所有外國所得稅及特許權稅務申報,報告和聲明,這是其所屬司法管轄區要求的;已支付了所有在這些申報、報告和聲明上表明或確定應支付的重大稅款和其他政府評估及費用;已在賬簿上預留了合理充足的準備金以支付除相關申報、報告或聲明適用的期間外的各個期間內所有重大稅款。任何司法管轄區的稅務機構均未向公司或任何子公司要求支付任何重大數額的未支付稅款,公司或任何子公司的高級管理人員均未獲悉任何這類要求的依據。

 

(gg) 外國腐敗行爲公司或其任何子公司,或據公司或其任何子公司盡職調查後得知的任何代理人或其他經授權代表公司或其任何子公司行事的人,沒有(i)直接或間接地使用任何基金進行與國內或國外政治活動有關的非法捐款、禮物、娛樂或其他非法支出,(ii)未經授權支付任何資金給國內或國外政府官員或僱員,也未向任何國內或國外政黨或政治活動使用公司資金進行非法支付,(iii)未充分披露公司或其任何子公司(或公司知曉的代表其行事的任何人)違反法律的任何捐款,或(iv)在任何重大方面違反了1977年修正案的《外國腐敗行爲法》的任何規定。

 

(hh) Accountants. JP Centurion & Partners PLT (the “Accountants”), which has expressed its opinion with respect to the audited financial statements and schedules included as a part of the Registration Statement, the General Disclosure Package and the Final Prospectus, is an independent public accounting firm with respect to the Company within the meaning of the Act and the Rules and Regulations.

 

(ii) Regulation M Compliance. The Company, its Subsidiaries, each of their respective directors, officers, Affiliates or controlling persons have not, and to its knowledge no one authorized to act on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Underwriters in connection with the Offering.

 

(jj) Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the best of the Company’s knowledge after due inquiry, any director, officer, agent, employee or Affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).

 

(kk) U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Representative’s request.

 

(ll) Bank Holding Company Act. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the “BHCA”), and to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve”). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

 

(mm) 洗黑錢. 本公司及其子公司的運營始終在物質上遵守適用的財務 記錄保留和報告要求,以及1970年《貨幣和外匯交易報告法》(經修訂)、適用的反洗錢法以及相關的規則和法規(統稱爲“反洗錢法)”,並且沒有針對本公司或任何子公司的涉及反洗錢法的任何訴訟或程序正在進行中,或者在經過適當調查後,根據本公司或任何子公司的最佳知識,未曾以書面形式威脅。

  

(nn)股權激勵 計劃除非在註冊聲明、普通披露包和招股說明書中另有說明,否則公司沒有任何股權激勵計劃。

 

11

 

 

(oo)證書. 由公司或其任何子公司的正式授權官員簽署的任何證明文件,交付給代表或其法律顧問,將被視爲公司對承銷商就所涵蓋事項所作的陳述和保證。

 

(pp)董事和官員調查表根據公司盡職調查後獲得的最好的信息,所有包含在問卷中的信息(「」問卷調查”),公司擬議之前,擬議之前立即收購的「管理」部分中提及的公司董事和管理人員各自填寫的“內部人員以及隨附在此的鎖定協議 附件A 向承銷商提供的所有信息在各方面均屬真實和正確,公司尚未發現任何可能導致內部人士填寫的調查問卷中披露的信息不準確和錯誤的信息。

 

(qq) 行業板塊數據;前瞻性聲明。 每份註冊聲明書、概括性披露文件和招股說明書中包含的統計和市場相關數據均基於或衍生自公司合理並真誠地認爲可靠和準確的來源,或代表公司基於從這些來源獲取的數據作出的真誠估計。 沒有在任何註冊聲明書、概括性披露文件或招股說明書(包括其中所有的修訂和補充)中插入或參照的前瞻性聲明(在《證券法》第27A條和《交易法》第21E條的意義下)是毫無合理依據地作出或重新確認的,或者沒有真誠地進行披露。

 

(rr)與股東有關的計劃或安排本公司及其任何附屬公司均未參與任何方案或安排,通過該方案或安排,股東或潛在股東被貸款、贈予或以其他方式獲得購買股份所需的資金,無論是在發售前、發售中還是發售後。本公司及其任何附屬公司對此類方案或安排並不知情,無論其是否爲正式協議的當事方。

 

(ss)材料收購 或處置公司及其任何子公司均未與任何有效的諒解備忘錄、意向書、最終協議或其他類似協議簽署,涉及合併、整合或資產、技術、業務單元或企業的收購或處置,這些協議需在註冊聲明、一般披露包和招股說明書中描述,但未如此描述。

 

(tt) 法律選擇;管轄權, 以太經典。. 根據下面第9(e)節的法律選擇對公司有效且可執行,按照其條款。持有證券的人和每個承銷商都有權在公司形成和居住地的管轄法院以原告身份提起訴訟,以執行他們在本協議和證券下的各自權利,且進入這些法院不受任何不適用於該管轄區居民或在該管轄區註冊公司的條件的限制。此處列出的賠償和貢獻條款不違反英屬維爾京群島或馬來西亞的法律或公共政策。

 

12

 

 

(vv) 基本報表,以太經典。 基本報表,包括其附註和註冊聲明中包含的支持性附表(如有), 定價披露包和招股說明書,公正地展現了公司的財務狀況、運營結果和現金流 在適用的日期和期間;該基本報表已根據國際會計準則委員會("IASB")發佈的國際財務報告準則("IFRS")編制, 在相關期間內的一致應用(前提是未經審計的臨時基本報表須接受年終審計 調整,這些調整的總體預期不會重大,並且不包含IFRS要求的所有腳註);並且註冊聲明中包含的任何支持性 附表公正地呈現所需說明的信息。除非包含其中,否則根據證券法或證券法法規,註冊聲明、定價披露包或招股說明書 不需要包含任何其他歷史或虛擬的基本報表或支持性附表。「調整後的」基本信息及其相關說明(如有),在註冊聲明、定價披露 包和招股說明書中已根據證券法及證券法法規的適用要求正確編制,並公正地呈現其中所示的信息,且在公司判斷中, 編制時使用的假設是合理的,且所用調整適當地反映了其中提到的交易和情況。所有在註冊聲明、定價披露包或招股說明書中 披露的關於「非公認會計原則財務指標」(按委員會規則和法規規定的該術語),如有,實質上符合交易法的G條款和證券法第10條(e) 條規程S-k,以適用爲準。註冊聲明、定價披露包和招股說明書披露了所有重大表外交易、安排、義務(包括或有義務) 以及公司與未合併實體或其他可能對公司的財務狀況、運營結果、流動性、資本支出、資本資源或收入或支出重大元件 產生重大當前或未來影響的其他關係。除非在註冊聲明、定價披露包和招股說明書中披露,(a) 自注冊聲明中包含的最後一份資產負債表之後,定價披露包和招股說明書, 公司或其任何直接或間接子公司,包括在註冊聲明、定價披露包和招股說明書中披露或描述爲子公司的每個實體, 未產生任何重大負債或義務,無論是直接或或有的,或進行任何重大交易,其他都是正常業務範圍內的,(b) 公司未宣佈或支付任何分紅派息或進行了任何關於其資本股票的任何分配, (c) 公司或其任何子公司的資本股票沒有發生任何變化,或,除正常業務範圍外,未進行任何股票補償計劃下的授予, 以及(d) 公司長期或短期債務未發生任何重大不利變更。公司表示,除在註冊聲明中列出的子公司外,它沒有任何直接或間接子公司。

 

4. (e)公司同意以下方式與承銷商達成一致:

 

(a) 註冊聲明的修正和補充。 公司在任何生效日期之前或之後,在法律要求交付招股說明書期間(無論是通過實體交付還是遵守規則與條例第172條或任何類似規則) (“(C) 任何允許的自由撰寫招股說明書在其發行日、任何銷售時間點和任何在之後的 Prospectus Delivery Period(下面定義)中(除非公司根據5(b)(iii)中描述,通知經紀人在此之前,除外)都不會包含與註冊聲明書、任何基礎招股說明書或招股說明書中包含的信息相沖突的任何信息。對於允許的自由撰寫招股說明書中的描述或省略,限於根據書面信息向公司提供的信息,對於公司明確地要求在其中使用,因此理解並同意,截至本協議日期,只能通過代理有關信息進行提交,其中包括第5(b)(ii)節中描述的信息。與承銷商或經銷商銷售證券有關的)修改或補充註冊聲明、一般披露包或招股說明書,除非相關當局另有要求,或該修正或補充的副本已首先在合理的時間內提交給代表, 在申請之前,或者如果不需要申請,則在使用該文件之前,且代表對此未提出善意異議。

 

(b) 對註冊聲明、一般披露文件和招股說明書及其他證券法事項的修訂和補充. 在招股說明書交付期間, 公司將遵守證券法、適用的規則和條例,以及交易法所強加給它的所有要求,以便允許按照本文件、一般披露文件、註冊聲明和招股說明書的規定繼續銷售或交易證券。如果在招股說明書交付期間,發生任何事件或者出現某種情況,導致一般披露文件或招股說明書(如經修訂或補充後)包括任何虛假陳述的重大事實,或者未能說明在當時情況下使其聲明不具誤導性所必需的任何重大事實,或者如果有必要修訂或補充一般披露文件或招股說明書,以使其聲明在當時情況下不具誤導性,或者如果代表認爲有必要修訂或補充註冊聲明、一般披露文件或招股說明書,或者提交包含招股說明書的新註冊聲明,以遵守法律、規則和條例、交易法或交易法規則,包括與招股說明書的交付相關, 公司同意 (i) 及時通知代表任何此類事件或情況,和 (ii) 及時準備(受第4(a)和第4(f)條款的限制)、向委員會提交(並盡力使註冊聲明的任何修訂或任何新註冊聲明被宣佈生效)並自費向代表提供(如適用,提供給經銷商)一般披露文件或招股說明書的修訂或補充,或者任何新註冊聲明,以使一般披露文件或招股說明書經修訂或補充後的聲明在當時情況下不具誤導性,或者使得經修訂或補充後的註冊聲明或招股說明書符合法律、規則和條例、交易法或交易法規則。

 

13

 

 

(c) 通知承銷商。 公司應及時通知代表,並以書面形式確認以下事項:(i)註冊聲明的任何事後生效修正案已生效以及該修正案的任何事後生效修正案已生效,(ii)委員會要求對註冊聲明或招股說明書進行修正或添加補充信息,(iii)委員會或任何州證券委員會就任何股票資格暫停在任何司法管轄區的發行或銷售的程序的開展或威脅的開始通知,包括但不限於,委員會發布任何停止訂單暫停註冊聲明生效或開展程序或威脅其目的,(iv)在招股說明期間發生的任何事件,公司判斷使註冊聲明或招股說明書中的任何陳述(包括遺漏)或不實或需要對註冊聲明或招股說明書進行任何更改以使其在其所做陳述的情況下不具誤導性(包括遺漏)的事件,併發送公司或公司代表收到的委員會關於公司、註冊聲明、任何初步招股說明書或招股說明書的任何其他通信(v)。如委員會隨時發佈暫停註冊聲明生效的任何命令,公司應盡最大努力在最早可能時刻撤回此命令。公司應遵守規則424(b)、430A、4300億和462(b)的規定,根據規則和規例進行所有必要的提交,並及時通知代表所有此類提交。

 

(d) Executed Registration Statement. The Company shall furnish to the Representative, without charge, one signed copy of the Registration Statement, and of any post-effective amendment thereto, including financial statements and schedules, and all exhibits thereto, and shall furnish to the Representative, without charge, a copy of the Registration Statement and any post-effective amendment thereto, including financial statements and schedules but without exhibits, provided however, that the Representative agrees that any Registration Statement filed with the Commission via EDGAR shall suffice.

 

(e) Undertakings. The Company shall comply with all the provisions of any undertakings contained and required to be contained in the Registration Statement.

 

(f) Prospectus. The Company shall prepare the Prospectus in a form approved by the Representative and shall file such Prospectus with the Commission pursuant to Rule 424(b) of the Rules and Regulations with a filing date not later than the second business day following the execution and delivery of this Agreement. Promptly after the effective date of the Registration Statement, and thereafter from time to time during the period when the Prospectus is required (or, but for the provisions of Rule 172 under the Act, would be required) to be delivered, the Company shall deliver to the Representative, without charge, as many copies of the Prospectus and any amendment or supplement thereto as the Representative may reasonably request. The Company consents to the use of the Prospectus and any amendment or supplement thereto, in the manner in compliance with the requirements imposed upon it by the Securities Act, as now and hereafter amended, and by the Rules and Regulations, as from time to time in force, and by the Exchange Act, by the Representative and by all dealers to whom the Shares may be sold, both in connection with the offering or sale of the Shares and for any period of time thereafter during the Prospectus Delivery Period. If, during the Prospectus Delivery Period any event shall occur that in the judgment of the Company or counsel to the Underwriters should be set forth in the Prospectus in order to make any statement therein, in light of the circumstances under which it was made, not misleading (including by omission), or if it is necessary to supplement or amend the Prospectus to comply with law, the Company shall forthwith prepare and duly file with the Commission an appropriate supplement or amendment thereto, and shall deliver to the Representative, without charge, such number of copies thereof as the Representative may reasonably request.

 

14

 

 

(g) Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the Representative, will not make, any offer relating to the Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I hereto. Any such free writing prospectus consented to by the Representative is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Shares or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

 

(h) Compliance with Blue Sky Laws. If required, prior to any public offering of the Securities by the Underwriters, the Company shall cooperate with the Representative and counsel to the Underwriters in connection with the registration or qualification (or the obtaining of exemptions from the application thereof) of the Shares for offer and sale under the securities or Blue Sky laws of such jurisdictions as the Representative may request, provided, however, that in no event shall the Company be obligated to qualify a public offering outside the United States or to do business as a foreign corporation in any jurisdiction where it is not now so qualified, to qualify or register as a dealer in securities, to take any action which would subject it to general service of process in any jurisdiction where it is not now so subject or subject itself to ongoing taxation in respect of doing business in any jurisdiction in which it is not so subject.

 

(i) Delivery of Financial Statements. During a period of one year commencing on the effective date of the Registration Statement applicable to the Underwriters, the Company shall furnish to the Representative and each other Underwriter who may so request copies of such financial statements and other periodic and special reports as the Company may from time to time distribute generally to the holders of any class of its capital stock, and will furnish to the Representative and each other Underwriter who may so request a copy of each annual or other report it shall be required to file with the Commission; provided, however, that the availability of electronically transmitted copies filed with the Commission pursuant to EDGAR shall satisfy the Company’s obligation to furnish copies hereunder.

 

(j) Availability of Earnings Statements. The Company shall make generally available to holders of its securities as soon as may be practicable but in no event later than the last day of the fifteenth (15th) full calendar month following the calendar quarter in which the effective date occurs in accordance with Rule 158 of the Rules and Regulations, an earnings statement (which need not be audited but shall be in reasonable detail) covering a period of twelve (12) months ended commencing after the effective date, and satisfying the provisions of Section 11(a) of the Act (including Rule 158 of the Rules and Regulations).

 

(k) Consideration; Payment of Expenses. In consideration of the services to be provided for hereunder, the Underwriters or their respective designees shall receive their pro rata portion (based on the Securities purchased) of the following compensation with respect to the Shares they are offering:

 

(i) An underwriting discount equal to seven percent (7%) of the aggregate gross proceeds raised in the Offering (the “Underwriting Discount”); and

 

(ii) The Representative’s Warrants; and

 

(iii) The Representative reserves the right to reduce any item of compensation or adjust the terms thereof as specified herein in the event that a determination shall be made by FINRA to the effect that the Underwriters’ aggregate compensation is in excess of FINRA rules or that the terms thereof require adjustment.

 

15

 

 

(iv) Whether or not the transactions contemplated by this Agreement, the Registration Statement and the Prospectus are consummated or this Agreement is terminated, the Company hereby agrees to pay the following:

 

(1) all expenses in connection with the preparation, printing, formatting for EDGAR and filing of the Registration Statement, any Preliminary Prospectus and the Prospectus and any and all exhibits, amendments and supplements thereto and the mailing and delivering of copies thereof to the Underwriters and dealers;

 

(2) all filing fees in connection with filings with FINRA’s Public Offering System;

 

(3) all fees, disbursements and expenses of the Company’s counsel, accountants and other agents and representatives in connection with the registration of the Securities under the Act and the Offering;

 

(4) all expenses in connection with the qualifications of the Securities for offering and sale under state or foreign securities or blue sky laws (including, without limitation, all filing and registration fees, and the fees and disbursements of Underwriters’ counsel;

 

(5) all fees and expenses in connection with listing the Securities on a national securities exchange;

 

(6) all expenses, including travel and lodging expenses, of the Company’s officers, directors and employees and any other expense of the Company incurred in connection with attending or hosting meetings with prospective purchasers of the Securities, any fees and expenses associated with the iDeal system and NetRoadshow, and all the road show expenses incurred by the Company;

 

(7) any stock transfer taxes or other taxes incurred in connection with this Agreement or the offering, including any stock transfer taxes payable upon the transfer of securities to the Underwriters;

 

(8) the costs associated with preparing, printing and delivering certificates representing the Securities;

 

(9) the cost and charges of any transfer agent or registrar for the Securities;

 

(10) subject to the following provision, other costs (including Underwriters’ counsel’s fees and expenses) and expenses incident to the Offering that are not otherwise specifically provided for in this Section 4(k);

 

(11) costs relating to background checks of the Company’s officers and directors;

 

provided, however, that all such costs and expenses (including Underwriters’ counsel’s fees and expenses) that are incurred by and reimbursable to the Underwriters shall not exceed $200,000 in the aggregate.

 

(l) Non-accountable Expenses. The Company further agrees that, in addition to the expenses payable pursuant to Section 4(k), on the Closing Date it shall pay to the Representative, by deduction from the net proceeds of the Offering contemplated herein, a non-accountable expense allowance equal to one percent (1%) of the aggregate gross proceeds raised in the Offering, provided, however, that in the event that the Offering is terminated, the Company agrees to reimburse the Underwriters pursuant to Section 4(m) hereof.

 

(m) Reimbursement of Expenses upon Termination of Agreement. Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Company shall reimburse the Underwriters for all out-of-pocket expenses (including the reasonable fees, disbursements and other charges of counsel to the Underwriter) actually incurred by the Underwriters in connection herewith and as allowed under FINRA Rule 5110 in the amount not to exceed $200,000.

 

(n) No Stabilization or Manipulation. The Company or its Subsidiaries shall not at any time, directly or indirectly, take any action intended to cause or result in, or which might reasonably be expected to cause or result in, or which will constitute, stabilization or manipulation, under the Act or otherwise, of the price of the Shares to facilitate the sale or resale of any of the Shares. 

 

16

 

 

(o) Use of Proceeds. The Company shall apply the net proceeds from the offering and sale of the Securities to be sold by the Company in the manner set forth in the General Disclosure Package and the Prospectus under “Use of Proceeds” and shall file such reports with the Commission with respect to the sale of the Securities and the application of the proceeds therefrom as may be required in accordance with Rule 463 under the Act.

 

(p) Lock-Up Agreements of Company, Management and Affiliates. The Company shall not, for a period of one hundred eighty (180) days after the effectiveness of the Registration Statement (the “Lock-Up Period”), without the prior written consent of USTS (which consent may be withheld in its sole discretion), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, or (2) file with the Commission a registration statement under the Act to register, any Ordinary Shares, warrants, or any securities convertible into or exercisable or exchangeable for Ordinary Shares, except for a Form S-8 registration statement. The foregoing sentence shall not apply to: (i) any exercise (including a cashless exercise or broker-assisted exercise and payment of tax obligations), vesting or settlement, as applicable, of options or warrants to purchase Ordinary Shares or other equity awards pursuant to any stock incentive plan or stock purchase plan of the Company; provided that any Ordinary Shares received by the Person upon such exercise, conversion or exchange will be subject to the Lock-Up Period, (b) any establishment of a trading plan pursuant to Rule 10b5-1 under the Exchange Act for the transfer of Ordinary Shares (a “Trading Plan”); provided that (i) the Trading Plan shall not provide for or permit any transfers, sales or other dispositions of Ordinary Shares during the Lock-Up Period and (ii) the Trading Plan would not require any filing under Section 16(a) of the Exchange Act and no such filing is voluntarily made, (c) any transfer of Ordinary Shares acquired in open market transactions following the closing of this Offering, provided the transfer would not require any filing under Section 16(a) of the Exchange Act and no such filing is voluntarily made, (d) the transfer of the Person’s Ordinary Shares or any security convertible into or exercisable or exchangeable for Ordinary Shares to the Company in connection with the termination of the Person’s employment with the Company or pursuant to contractual arrangements under which the Company has the option to repurchase such shares, provided that no filing by any party under the Exchange Act shall be required or shall be made voluntarily within 45 days after the date the Person ceases to provide services to the Company, and after such 45th day, if the Person is required to file a report under the Exchange Act reporting a reduction in beneficial ownership of Ordinary Shares during the Lock-Up Period, the Person shall indicate in the footnotes thereto that the filing relates to the termination of the Person’s employment, and no other public announcement shall be made voluntarily in connection with such transfer (other than the filing on a Form 5, or such successor form, made after the expiration of the Lock-Up Period), (e) the conversion of the outstanding securities into Ordinary Shares, provided that any such Ordinary Shares received upon such conversion shall be subject to the restrictions on transfer set forth in this Lock-Up Agreement, or (f) the transfer of Ordinary Shares or any security convertible into or exercisable or exchangeable for Ordinary Shares pursuant to a bona fide third-party tender offer for securities of the Company, merger, consolidation or other similar transaction that is approved by the disinterested members of the board of directors of the Company, made to all holders of Ordinary Shares involving a change of control, provided that all of the securities subject to the Lock-Up Agreement shall remain subject to the restrictions therein. The Company has caused each of its officers and directors and shareholders of five percent (5%) or more of the outstanding Ordinary Shares of the Company to enter into agreements with the Representative in the form set forth in Exhibit A.

 

(q) Lock-Up Releases. If USTS, in its sole discretion, agrees to release or waive the restrictions set forth in a lock-up letter described in Section 4(p) hereof for an officer or director of the Company and provides the Company with notice of the impending release or waiver at least three Business Days before the effective date of the release or waiver, the Company agrees to announce the impending release or waiver by a press release substantially in the form of Exhibit B hereto through a major news service at least two Business Days before the effective date of such release or waiver, or any other method that satisfies the obligations described in FINRA Rule 5131(d)(2) at least two Business Days before the effective date of the release or waiver.

 

(r) NASDAQ listing. The Company will use its reasonable best efforts to effect and maintain the listing of the Ordinary Shares on the NASDAQ Capital Market for at least three (3) years after the Closing Date.

 

17

 

 

5. Conditions of the Obligations of the Underwriters. The obligation of the Underwriters to purchase the Firm Shares on the Closing Date or the Option Shares on the Option Closing Date, as the case may be, as provided herein is subject to the accuracy of the representations and warranties of the Company, the performance by the Company of its covenants and other obligations hereunder and to the following additional conditions:

 

(a) Post Effective Amendments and Prospectus Filings. Notification that the Registration Statement has become effective shall be received by the Representative not later than 4:30 p.m., New York City time, on the date of this Agreement or at such later date and time as shall be consented to in writing by the Representative and all filings made pursuant to Rules 424, 430A, or 430B of the Rules and Regulations, as applicable, shall have been made or will be made prior to the Closing Date in accordance with all such applicable rules.

 

(b) No Stop Orders, Requests for Information and No Amendments. (i) No stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall be pending or are, to the best knowledge of the Company after due inquiry, threatened by the Commission, (ii) no order suspending the qualification or registration of the Securities under the securities or Blue Sky laws of any jurisdiction shall be in effect and no proceeding for such purpose shall be pending before or threatened or contemplated by the authorities of any such jurisdiction, (iii) any request for additional information on the part of the staff of the Commission or any such authorities shall have been complied with to the satisfaction of the staff of the Commission or such authorities and (iv) after the date hereof no amendment or supplement to the Registration Statement or the Prospectus shall have been filed unless a copy thereof was first submitted to the Representative and the Representative did not object thereto in good faith, and the Representative shall have received certificates, dated the Closing Date and the Option Closing Date and signed by the Chief Executive Officer or the Chairman of the Board of Directors and the Chief Financial Officer of the Company in their capacities as such, and not individually, (who may, as to proceedings threatened, certify to their knowledge), to the effect of clauses (i), (ii) and (iii).

 

(c) No Material Adverse Changes. Since the respective dates as of which information is given in the Registration Statement and the Prospectus, except as set forth in the Registration Statement, the General Disclosure Package and the Prospectus (i) there shall not have been a Material Adverse Change, (ii) the Company shall not have incurred any material liabilities or obligations, direct or contingent, (iii) the Company shall not have entered into any material transactions not in the ordinary course of business other than pursuant to this Agreement and the transactions referred to herein, (iv) the Company shall not have issued any securities (other than the Securities or the Ordinary Shares issued in the ordinary course of business pursuant to existing employee benefit plans of the Company referred to in the Registration Statement, General Disclosure Package and the Prospectus) or declared or paid any dividend or made any distribution in respect of its capital stock of any class or debt (long-term or short-term), and (v) no material amount of the assets of the Company shall have been pledged, mortgaged or otherwise encumbered.

 

(d) No Actions, Suits or Proceedings. Since the respective dates as of which information is given in the Registration Statement, the General Disclosure Package and the Prospectus, there shall have been no actions, suits or proceedings instituted, or to the best of the Company’s knowledge after due inquiry, threatened against or affecting, the Company or its subsidiaries or any of their respective officers in their capacity as such, before or by any federal, state or local court, commission, regulatory body, administrative agency or other governmental body, domestic or foreign.

 

(e) All Representations True and Correct and All Conditions Fulfilled. Each of the representations and warranties of the Company contained herein shall be true and correct as of the date of the Agreement and at the Closing Date as if made at the Closing Date and any Option Closing Date, as the case may be, and all covenants and agreements contained herein to be performed by the Company and all conditions contained herein to be fulfilled or complied with by the Company at or prior to the Closing Date and any Option Closing Date, shall have been duly performed, fulfilled or complied with.

 

(f) Opinions of Counsel to the Company. The Representative shall have received the opinions, each dated the Closing Date and any Option Closing Date, as the case may be, each reasonably satisfactory in form and substance to the Representative and counsel for the Underwriters, from: (i) Hunter Taubman Fischer & Li LLC, as United States securities counsel to the Company, including and a written statement providing certain “10b-5” negative assurances; (ii) Ilham Lee, as Malaysia counsel to the Company; and (iii) Mourant Ozannes, as British Virgin Islands counsel to the Company.

 

18

 

 

(g) Opinion of Counsel to the Underwriters. The Representative shall have received an opinion and a written statement providing certain “10b-5” negative assurances, dated the Closing Date and any Option Closing Date, as the case may be, from (i) Sichenzia Ross Ference Carmel LLP, U.S. securities counsel to the Underwriters, and (ii) Lee & Poh Partnership, Malaysia Counsel to the Underwriters, with respect to the Registration Statement, the Prospectus and this Agreement, which opinions shall be satisfactory in all respects to the Representative.

 

(h) Accountants’ Comfort Letter. On the date of the Prospectus, the Representative shall have received from the Accountants a letter dated the date of its delivery, addressed to the Underwriters, in form and substance reasonably satisfactory to the Representative and counsel to the Underwriters, containing statements and information of the type ordinarily included in accountant’s “comfort letters” to underwriters, delivered according to Statement of Auditing Standards No. 72 (or any successor bulletin), with respect to the audited and unaudited financial statements and certain financial information contained in the Registration Statement and the Prospectus. At the Closing Date and any Option Closing Date, as the case may be, the Representative shall have received from the Accountants a letter dated such date, in form and substance reasonably satisfactory to the Representative and counsel to the Underwriters, to the effect that they reaffirm the statements made in the letter furnished by them pursuant to the preceding sentence and have conducted additional procedures with respect to certain financial figures included in the Prospectus, except that the specified date referred to therein for the carrying out of procedures shall be no more than three Business Days prior to the Closing Date or any Option Closing Date, as the case may be.

 

(i) Certificates:

 

(I) Officers’ Certificate. The Company shall have furnished to the Representative a certificate in a form substantially similar to the form attached as Exhibit C hereto, dated the Closing Date and any Option Closing Date (if such date is other than the Closing Date), of its Chief Executive Officer and its Chief Financial Officer stating that (A) such officers have carefully examined the Registration Statement, the General Disclosure Package, any Issuer Free Writing Prospectus, and the Prospectus and, in their opinion and to the best of their knowledge, the Registration Statement and each amendment thereto, as of the Applicable Time and as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date) did not include any untrue statement of a material fact and did not omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading, and the General Disclosure Package, as of the Applicable Time and as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date), any Issuer Free Writing Prospectus as of its date and as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date), the Prospectus and each amendment or supplement thereto, as of the respective date thereof and as of the Closing Date, did not include any untrue statement of a material fact and did not omit to state a material fact necessary in order to make the statements therein, in light of the circumstances in which they were made, not misleading, (B) since the effective date of the Registration Statement, to the best of their knowledge, no event has occurred which should have been set forth in a supplement or amendment to the Registration Statement, the General Disclosure Package, or the Prospectus, (C) to the best of their knowledge, as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date), the representations and warranties of the Company in this Agreement are true and correct in all material respects (except for those representations and warranties qualified as to materiality, which shall be true and correct in all respects and except for those representations and warranties which refer to facts existing at a specific date, which shall be true and correct as of such date) and the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date (or any Option Closing Date if such date is other than the Closing Date), and (D) to the best of their knowledge, there has not been, subsequent to the date of the most recent audited financial statements included or incorporated by reference in the General Disclosure Package, a Material Adverse Change.

 

(II) Secretary’s Certificate. At each of the Closing Date and any Option Closing Date, the Representative shall have received a certificate of the Company in a form substantially similar to the form attached as Exhibit D hereto, signed by the Secretary of the Company, dated the Closing Date or the Option Date, as the case may be.

(III) Chief Financial Officer Certificate. On the Closing Date or any Option Closing Date, as the case may be, the Company shall have furnished to the Representative a certificate of the Company’s Chief Financial Officer, dated the respective dates of their delivery and signed by the Chief Financial Officer and addressed to the Representative, with respect to certain operating and financial data contained in each of the Registration Statement, the General Disclosure Package and the Prospectus, providing “management comfort” with respect to such information, in form and substance satisfactory to the Representative and substantially similar to the form attached as Exhibit E hereto.

 

19

 

 

(j) Transfer Agent’s Certificate. The Company’s transfer agent shall have furnished or caused to be furnished to the Representative a certificate satisfactory to the Representative of one of its authorized officers with respect to the issuance of the Shares and such other customary matters related thereto as the Representative may reasonably request.

 

(k) Eligible for DTC Clearance. At or prior to the Closing Date and each Option Closing Date, the Shares shall be eligible for clearance and settlement through the facilities of the DTC.

 

(l) Lock-Up Agreements. At the date of this Agreement, the Representative shall have received the executed “lock-up” agreements referred to in Section 4(p) hereof from the Company’s officers and directors and shareholders holding more than 5% of the Company’s outstanding shares listed in Schedule III hereto.

 

(m) Stock Exchange Listing. The Shares shall have been duly authorized for listing on the NASDAQ Capital Market, subject to official notice of issuance.

 

(n) Exchange Act Registration. One or more registration statements in respect of the Shares have been filed on Form 8-A pursuant to Section 12(b) of the Exchange Act, each of which registration statement complies in all material respects with the Exchange Act.

 

(o) Good Standing. At the Closing Date and any Option Closing Date, the Company shall have furnished to the Representative satisfactory evidence of the good standing of the Company and its subsidiaries, in their respective jurisdictions of organization (to the extent the concept of “good standing” or such equivalent concept exists under the laws of the applicable jurisdictions), in each case in writing or any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions. If the applicable jurisdiction does not have a concept of “good standing,” the Company will furnish evidence in writing or any standard form of telecommunication from the appropriate governmental authorities that the relevant company was duly incorporated and remains duly registered in the jurisdiction of its incorporation.

 

(p) Company Certificates. The Company shall have furnished to the Representative such certificates, in addition to those specifically mentioned herein, as the Representative may have reasonably requested as to the accuracy and completeness at the Closing Date and any Option Closing Date of any statement in the Registration Statement, the General Disclosure Package or the Prospectus, as to the accuracy at the Closing Date and any Option Closing Date of the representations and warranties of the Company herein, as to the performance by the Company of its obligations hereunder, or as to the fulfillment of the conditions concurrent and precedent to the obligations hereunder of the Underwriters.

 

(q) No Objection. FINRA has confirmed that it has not raised any objection with respect to the fairness and reasonableness of the underwriting terms and arrangements relating to the offering of the Shares.

 

If any of the conditions hereinabove provided for in this Section 5 shall not have been fulfilled when and as required by this Agreement to be fulfilled, the obligations of the Underwriters hereunder may be terminated by the Representative by notifying the Company of such termination in writing at or prior to the Closing Date or any Option Closing Date, as the case may be.

 

6. Indemnification.

 

(a) Indemnification of the Underwriters. The Company shall indemnify and hold harmless each Underwriter, its Affiliates, the directors, officers, employees and agents of such Underwriter and each person, if any, who controls such Underwriter within the meaning of Section 15 of the Act or Section 20 of the Exchange Act from and against any and all losses, claims, liabilities, expenses and damages (including any and all investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding between any of the indemnified parties and any indemnifying parties or between any indemnified party and any third party, or otherwise, or any claim asserted), to which they, or any of them, may become subject under the Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, liabilities, expenses or damages arise out of or are based on (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), including the information deemed to be a part of the Registration Statement at the time of effectiveness and at any subsequent time pursuant to Rules 430A and 430B of the Rules and Regulations, as applicable, or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading or (ii) any untrue statement or alleged untrue statement of a material fact contained in any preliminary prospectus, any preliminary prospectus supplement, any Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement to any of the foregoing) or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading or (iii) any untrue statement or alleged untrue statement of a material fact contained in any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Securities, including any roadshow or investor presentations made to investors by the Company (whether in person or electronically) (collectively, Marketing Materials”) or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading or (iv) in whole or in part any inaccuracy in any material respect in the representations and warranties of the Company contained herein; provided, however, that the Company shall not be liable to the extent that such loss, claim, liability, expense or damage is based on any untrue statement or omission or alleged untrue statement or alleged omission made in reliance on and in conformity with Underwriters’ Information. This indemnity agreement will be in addition to any liability that the Company might otherwise have.

 

20

 

 

(b) Indemnification of the Company. Each Underwriter, severally and not jointly, agrees to indemnify and hold harmless the Company, its Affiliates, the directors, officers, employees and agents of the Company and each other person or entity, if any, who controls the Company within the meaning of Section 15 of the Act or Section 20 of the Exchange Act, against any losses, liabilities, claims, damages and expenses whatsoever, as incurred (including but not limited to reasonable attorneys’ fees and any and all reasonable expenses whatsoever, incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, and any and all amounts paid in settlement of any claim or litigation), joint or several, to which they or any of them may become subject under the Act, the Exchange Act or otherwise, insofar as such losses, liabilities, claims, damages or expenses (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement at the time of effectiveness and at any subsequent time pursuant to Rules 430A and 430B of the Rules and Regulations, any Preliminary Prospectus, the Prospectus, or any amendment or supplement to any of them, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that any such loss, liability, claim, damage or expense (or action in respect thereof) arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon the Underwriters’ Information; provided, however, that in no case shall any Underwriter be liable or responsible for any amount in excess of the underwriting discount and commissions applicable to the Securities purchased by such Underwriter hereunder. The parties agree that such information provided by or on behalf of the Underwriters through the Representative consists solely of the material referred to in the last sentence of Section 3(c) hereof.

 

(c) Indemnification Procedures. Any party that proposes to assert the right to be indemnified under this Section ‎6 shall, promptly after receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this Section ‎6, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify such indemnifying party shall not relieve the indemnifying party from any liability that it may have to any indemnified party under the foregoing provisions of this Section ‎6 unless, and only to the extent that, such omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable out-of-pocket costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (i) the employment of counsel by the indemnified party has been authorized in writing by one of the indemnifying parties in connection with the defense of such action and that indemnifying party agrees to pay the fees and expenses of such counsel, (ii) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (iii) the indemnified party has reasonably concluded that a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party shall not have the right to direct the defense of such action on behalf of the indemnified party), (iv) the indemnifying party does not diligently defend the action after assumption of the defense, or (v) the indemnifying party has not in fact employed counsel satisfactory to the indemnified party to assume the defense of such action within a reasonable time after receiving notice of the commencement of the action, in each of which cases the reasonable fees, disbursements and other charges of counsel shall be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one separate firm admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All such fees, disbursements and other charges shall be reimbursed by the indemnifying party promptly as they are incurred. An indemnifying party shall not be liable for any settlement of any action or claim effected without its written consent (which consent will not be unreasonably withheld or delayed). No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this Section ‎6 (whether or not any indemnified party is a party thereto), unless (x) such settlement, compromise or consent (i) includes an unconditional release of each indemnified party from all liability arising or that may arise out of such claim, action or proceeding and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party, and (y) the indemnifying party confirms in writing its indemnification obligations hereunder with respect to such settlement, compromise or judgment. Notwithstanding the foregoing, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by Section 6(a) effected without its written consent if (A) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (B) such indemnifying party shall have received notice of the terms of such settlement at least 30 days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.

 

21

 

 

(d) Contribution. In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs of this Section ‎6 is applicable in accordance with its terms but for any reason is held to be unavailable, the Company and the Underwriters shall contribute to the total losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted, but after deducting any contribution received by the Company from persons other than the Underwriters, such as persons who control the Company within the meaning of the Act, officers of the Company who signed the Registration Statement and directors of the Company, who may also be liable for contribution), to which the Company and the Underwriter may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other from the offering of the Securities pursuant to this Agreement. The relative benefits received by the Company and the Underwriters shall be deemed to be in the same proportion as (x) the total proceeds from the Offering (net of underwriting discount and commissions but before deducting expenses) received by the Company bears to (y) the underwriting discount and commissions received by the Underwriters, in each case as set forth in the table on the cover page of the Prospectus. If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and the Underwriters, on the other, with respect to the statements or omissions which resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering. Such relative fault shall be determined by reference to whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Underwriters, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Underwriters agree that it would not be just and equitable if contributions pursuant to this Section 6(d) were to be determined by pro rata allocation or by any other method of allocation (even if the Underwriters were treated as one entity for such purpose) which does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense or damage, or action in respect thereof, referred to above in this Section 6(d) shall be deemed to include, for purpose of this Section 6(d), any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section 6(d), no Underwriter shall be required to contribute any amount in excess of the underwriting discounts and commissions received by it. No person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 6(d), any person who controls a party to this Agreement within the meaning of the Act will have the same rights to contribution as that party, and each officer of the Company who signed the Registration Statement will have the same rights to contribution (but no personal obligation to contribute) as the Company, and each director, officer, employee, counsel or agent of an Underwriter will have the same rights to contribution as such Underwriter (but no personal obligation to contribute), subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect of which a claim for contribution may be made under this Section 6(d), will notify any such party or parties from whom contribution may be sought, but the omission so to notify will not relieve the party or parties from whom contribution may be sought from any other obligation it or they may have under this Section 6(d). The obligations of the Underwriters to contribute pursuant to this Section 6(d) are several in proportion to the respective number of Securities to be purchased by each of the Underwriters hereunder and not joint. No party will be liable for contribution with respect to any action or claim settled without its written consent (which consent will not be unreasonably withheld).

 

(e) Survival. The indemnity and contribution agreements contained in this Section ‎6 and the representations and warranties of the Company contained in this Agreement shall remain operative and in full force and effect regardless of (i) any investigation made by or on behalf of any Underwriter or any controlling Person thereof, (ii) acceptance of any of the Securities and payment therefor or (iii) any termination of this Agreement.

 

7. Termination. The obligations of the Underwriters under this Agreement may be terminated at any time prior to the Closing Date (or, with respect to the Option Shares, on or prior to the Option Closing Date), by notice to the Company from the Representative, without liability on the part of the Underwriters to the Company, if, prior to delivery and payment for the Firm Shares (or the Option Shares, as the case may be), in the sole judgment of the Representative, any of the following shall occur:

 

(a) trading or quotation in any of the equity securities of the Company shall have been suspended or limited by the Commission, or The Nasdaq Stock Market;

 

22

 

 

(b) trading in securities generally on the New York Stock Exchange, the NYSE MKT, the NASDAQ Capital Market, the NASDAQ Global Market, the NASDAQ Global Select Market shall have been suspended or limited or minimum or maximum prices shall have been generally established on such exchange, or additional material governmental restrictions, not in force on the date of this Agreement, shall have been imposed upon trading in securities generally by such exchange or by order of the Commission or any court or other governmental authority;

 

(c) a general banking moratorium shall have been declared by any of U.S. federal or New York banking authorities;

 

(d) the United States shall have become engaged in new hostilities, there shall have been an escalation in hostilities involving the United States or there shall have been a declaration of a national emergency or war by the United States or there shall have occurred such a material adverse change in general economic, political or financial conditions, including, without limitation, as a result of terrorist activities after the date hereof (or the effect of international conditions on the financial markets in the United States shall be such), or any other calamity or crisis shall have occurred, the effect of any of which is such as to make it impracticable or inadvisable to market the Securities on the terms and in the manner contemplated by the Prospectus;

 

(e) the Company shall have sustained a loss material or substantial to the Company by reason of flood, fire, accident, hurricane, earthquake, theft, sabotage, or other calamity or malicious act, whether or not such loss shall have been insured, the effect of any of which is such as to make it impracticable or inadvisable to market the Securities on the terms and in the manner contemplated by the Prospectus;

 

(f) any domestic or international event or act or occurrence has materially disrupted, or in the reasonable opinion of the Underwriters will in the immediate future materially disrupt, the market for the Company’s securities or securities in general; or

 

(g) there shall have been a Material Adverse Change.

 

8. Underwriter Default.

 

(a) 如果任何承銷商或承銷商集團未能履行其購買本協議下的普通股的義務,並且與此違約有關的證券 (“違約證券”)在扣除代表根據以下第(b)款所作的安排後,整體不超過普通股數量的10%,每個未違約的承銷商,單獨行動而非共同,同意從公司購買數量相同的違約證券,數量與購買的所有違約證券的總數成同樣比例,正如該承銷商在此所列示的普通股數量與非違約承銷商名下的普通股總數的關係; 但前提是,代表可自行決定進行調整以消除碎股。 附表A

 

(b) 如果違約證券的總數超過公司股份數量的10%,代表可自行決定安排自身或其它方(包括任何同意的非違約承銷商或承銷商)按照本協議約定的條款購買違約證券。 如果在違約後的五(5)個日曆日內,代表未按照第8條規定購買違約證券,則協議將立即終止,公司對此不承擔任何責任(但應在第4(k)、(m)和6條款項下,或承銷商提供的情況除外),承銷商除外(在第6條中提及),但本協議的任何條款不得減輕違約的承銷商對其他承銷商和公司因其違約而造成的損害,如果有的話。

 

23

 

 

(c) 在非違約承銷商購買違約證券,或由其他方購買的情況下,代表或公司將有權將截止日期延遲最多五(5)個工作日,以便在註冊聲明、招股說明書或其他文件和安排中可能需要進行的任何更改,並且公司同意及時提交任何標的股票律師認爲可能需要或值得的註冊聲明或招股說明書的修正或補充。本協議中所使用的「承銷商」一詞將包括本第8節所替換的任何一方,其效果與如果其最初是本協議的一方相同,就該標的股而言。

 

9. 雜項.

 

(a) 通知。 本協議各方應以書面形式並送達給本協議下對方所指出住址(或根據本節規定不時接受方可能指定的任何其他地址)的所有通知、請求、同意、索賠、要求、放棄權利和其他通信。Notice本協議各方應通過親自遞送、全國公認的隔夜快遞(所有費用預付)、電子郵件(傳輸確認)、或經認證或掛號郵寄(在每種情況下,要求回執,預付郵費)方式送達所有通知。除本協議另有規定外,通知只在(a)接受方接收後生效,且(b)發送通知的一方遵守本節要求時有效。

 

如果是公司的通知:

17號,阿斯塔納1B街
萬達武吉拉惹,41050 蘭歌
雪蘭莪達魯埃斯干,馬來西亞

郵箱:ericlee@founderenergy.com.my

注意:首席執行官李成祺

 

若發送至代表或承銷商:

麥迪遜大道437號,27 樓層,

紐約,紐約州10022

郵箱:Lei.Huang@ustigersecurities.com 和 jack.
ye@ustigersecurities.com

注意:美洲虎證券公司,ECm部門

 

Attention:David Feirstein,P.C。

Sichenzia Ross Ference Carmel LLP。

美洲大道1185號,31st 樓層

紐約市,10036

電子郵件:rcarmel@srfc.law

注意:Ross Carmel律師。

 

(b) 第七條. 其他 第7.2節. 無第三方受益人。 本存款協議僅爲公司、託管人、所有者和持有人及其各自的繼承人的獨家利益,則不得被視爲授予任何其他人任何法律或衡平權利、救濟或索賠。 此協議僅爲承銷商、公司,以及在第6條中提到的受控人、董事、高管、僱員、律師和代理人,及其各自的繼任者和受讓人的利益而訂立,其他人不得在本協議項下取得或享有任何權利。本協議中所使用的"繼任者和受讓人"一詞不包括任何購買人以其作爲這種購買人從任何承銷商購買證券的情況,以及這種購買人從這樣的承銷商購買證券。

 

24

 

 

(c) 代表和保證的生存 所有列於此或根據本協議交付的證書或其他文書中公司的陳述、保證和協議, 應保持有效且完全有效,無論承銷商或其任何控制人所進行的任何調查如何,並應在本協議項下證券的交付和付款後繼續有效。

 

(d) 免責聲明 受託人關係公司承認並同意:(i)根據本協議購買和銷售有價證券的事項,包括確定股票的發行價格及任何相關折扣和佣金,屬於公司和承銷商之間的以自主決策爲基礎的商業交易;(ii)與本協議擬議的發行交易及其過程有關,承銷商一直並將繼續只按照本協議所設立的合同關係行事,不是公司或其安防-半導體持有人、債權人、僱員或任何其他方的代理人或受託人;(iii)沒有承銷商承擔或將承擔任何關於本協議擬議的有價證券發行或其過程的諮詢或託管責任(不論該承銷商或其關聯公司是否此前或目前就其他事項向公司提供建議),每位承銷商對於本協議擬議的有價證券發行除了在本協議明確規定的義務外,都沒有義務承擔對公司的責任;(iv)承銷商及其關聯公司可能涉及一系列交易,這些交易的利益不同於公司的利益;(v)沒有承銷商就本協議擬議的發行交易向公司提供任何法律、會計、監管或稅務建議,公司已就該事宜請教了其自己的法律、會計、監管和稅務顧問,至公司認爲適當的範圍。

 

(e) 適用法律: 此認股權證應受特拉華州內部法律的約束和解釋,並按照特拉華州的法律解決所有有關此認股權證的問題,而無需考慮任何(無論來自特拉華州或任何其他司法轄區的)規定或規則,這些規定或規則會導致適用特拉華州以外任何司法轄區的法律。本公司在此不可撤銷地放棄個人送達程序,並同意將副本郵寄到證券購買協議第9(f)條中所列地址以服務於任何此類訴訟、訴訟或程式化性的工作,並同意該服務構成恰當和充分的法律程序和任何通知。本公司在此不可撤銷地提交專屬管轄權爲威爾明頓特拉華州的州和聯邦法院,以裁決任何爭端或與本認股權證或本聲明中討論的任何交易有關的事宜,並在此不可撤銷地放棄並同意不在任何訴訟、訴訟或程序中聲稱其不是個人受到任何此類法院管轄,以使訴訟、訴訟或程序在不方便的論壇被提出或此類訴訟、訴訟或程序的地點是不恰當的。這裏所描述的任何內容均不被視爲以任何方式限制任何按法律允許的方式進行送達的權利。這裏所描述的任何內容均不被視爲或具有排除的效力,不適用於持有人在任何其他司法轄區起訴或採取其他法律行動,這些法律行動旨在收回公司對持有人的義務、實現該義務的任何抵押或任何其他擔保,或者在持有人的勝訴或其他法院裁定的情況下執行此份授權書。 本協議應受紐約州法律管轄並按其解釋,適用於完全在該州內履行的協議。

 

(f) 接受司法管轄公司不可撤銷地接受提交到紐約州或美國聯邦法院,位於紐約市曼哈頓區的任何訴訟、訴訟或程序,涉及本協議、披露文件、招股說明書、註冊聲明或證券發行。公司不可撤銷地放棄,儘可能地法律允許的範圍內,現在或今後對於在該法院提起的任何此類訴訟、訴訟或程序的地點提出異議,並且對於任何在該法院提起的任何此類訴訟、訴訟或程序被提起在不便利的論壇中的主張。至於公司現在或今後可能獲得的任何豁免(基於主權或其他原因)使其免於任何法院的管轄權或免受與其本身或其財產有關的任何法律程序的約束,公司不可撤銷地放棄,儘可能地法律允許的範圍內,在任何此類訴訟、訴訟或程序中免除此種豁免,包括但不限於根據1976年的《美國外國主權豁免法》修正案的任何豁免。包銷商和公司進一步同意接受並承認可能在紐約州紐約縣最高法院或紐約南部地區聯邦地區法院提起的任何和所有程序的送達,並同意將透過掛號信郵寄或通過聯邦快遞隔夜遞送交至公司地址的程序視爲對公司在任何此類訴訟、訴訟或程序中進行程序送達的有效行爲,將透過掛號信郵寄或通過聯邦快遞隔夜遞送至包銷商地址的程序視爲對該包銷商在任何此類訴訟、訴訟或程序中進行程序送達的有效行爲。

 

(g) 判決貨幣. 如果爲了在任何法院獲得判決,有必要將此下應支付的金額轉換爲除了美元以外的任何貨幣,雙方同意在法律允許的最大範圍內,所使用的交易所匯率應爲承銷商按照正常銀行程序能夠在紐約市於最終判決前的工作日用該其他貨幣購買美元的匯率。公司對承銷商或任何控制該承銷商的人的任何應付款項的義務,儘管有任何以其他貨幣作出的判決,在承銷商或控制人的接收該其他貨幣的首個工作日之前,不得解除,且僅在承銷商或控制人可以根據正常銀行程序以該其他貨幣購買到美元的情況下。若所購買的美元少於原本應支付給該承銷商或控制人的金額,公司同意作爲一個獨立的義務,儘管有任何此類判決,賠償該承銷商或控制人發生的損失。如果所購買的美元多於原本應支付給該承銷商或控制人的金額,該承銷商或控制人同意向公司支付所購美元與原本應支付金額之間的差額。

 

25

 

 

(h) Counterparts. This Agreement may be signed in two or more counterparts with the same effect as if the signatures thereto and hereto were upon the same instrument.

 

(i) Survival of Provisions Upon Invalidity of Any Single Provision. In case any provision in this Agreement shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

 

(j) Waiver of Jury Trial. The Company and each Underwriter each hereby irrevocably waive any right they may have to a trial by jury in respect of any claim based upon or arising out of this Agreement or the transactions contemplated hereby.

 

(k) Titles and Subtitles. The titles of the sections and subsections of this Agreement are for convenience and reference only and are not to be considered in construing this Agreement.

 

(l) Entire Agreement. This Agreement embodies the entire agreement and understanding between the parties hereto and supersedes all prior agreements and understandings relating to the subject matter hereof. This Agreement may not be amended or otherwise modified or any provision hereof waived except by an instrument in writing signed by the parties hereto.

 

[Signature page follows.]

 

26

 

 

If the foregoing correctly sets forth your understanding, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement among us.

 

  Very truly yours,
   
  FOUNDER GROUP LIMITED
     
  By:  /s/ Lee Seng Chi
  Name:   Lee Seng Chi
  Title: Chief Executive Officer, Director and
Chairman of the Board of Directors

 

Accepted by the Representative, acting for itself and as

Representative of the Underwriters named on Schedule A hereto,

as of the date first written above:

 

US TIGER SECURITIES, INC.  
     
By:   /s/ Jack Ye  
Name:  Jack Ye  
Title:  Managing Director  

 

 

 

 

附表A

 

Name of Underwriter  Number of
Firm Shares
   Number of
Option Shares
   Total Shares 
US Tiger Securities, Inc.   1,218,750    182,813    1,401,563 
Total   1,218,750    182,813    1,401,563 

 

 

 

 

Schedule I

 

ISSUER FREE WRITING PROSPECTUSES:

 

None.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule II

 

Pricing Information

 

Number of Firm Shares: 1,218,750

 

Number of Option Shares: 182,813

 

Public Offering Price per Firm Share: $4.00

 

Public Offering Price per Option Share: $4.00

 

Underwriting Discount per Firm Share: $0.28

 

Underwriting non-accountable expense allowance per Firm Share: $0.04

 

 

 

 

Schedule III

 

List of Lock-Up Parties

 

 

 

Lee Seng Chi

See Sian Seong

Thien Chiet Chai

Marco Baccanello

Sin Siew Kuen

Baharin Bin Din

Reservoir Link Energy Bhd.

CNP Equity Limited

 

 

 

 

附件A

 

鎖定協議

 

[___], 2024

 

美國虎牌證券公司。

麥迪遜大道437號,27 紐約紐約10022

 

  關於: 創始人集團有限公司

 

女士們,先生們:

 

作爲對美國猛虎的誘惑 Securities, Inc.,作爲承銷商的代表( 「代表」),執行承保 協議( 「承保協議」) 提供公開發行( 「優惠」) 普通股(”普通股”),沒有面值( 「股票」 或”證券”), 根據英屬維爾京群島法律註冊成立的股份有限公司方正集團有限公司的旗下( 「公司」), 下列簽署人特此同意,在規定的期限內,在任何情況下均未經代表事先書面同意 在接下來的第二段中( 「封鎖期」),下列簽署人不會:(1)要約、質押、宣佈 意向出售、出售、簽訂賣出合約、出售任何期權或購買合約、購買任何期權或賣出合約、授予 購買、賣空或以其他方式直接或間接轉讓或處置任何股份的任何期權、權利或擔保證 或任何可轉換成、可行使或可交換爲或代表獲得股份權利的證券(包括,不包括 限制,根據規則和條例,可能被視爲由下列簽署人實益擁有的股份 美國證券交易委員會(””)以及行使股票時可能發行的證券 選項)無論是現在擁有還是後來被收購( 「下列簽名的證券」) 或 (2) 文件或導致 向美國證券交易委員會提交任何與發行有關的註冊聲明(不包括S-8表格上的註冊聲明) 公司的普通股。明確同意上述限制禁止下列簽署人進行任何套期保值 或其他旨在或可以合理預期會導致或導致下列簽署人出售或處置的交易 證券,即使此類下籤人的證券將由下列簽署人以外的其他人處置。這種禁止的套期保值 或其他交易將包括但不限於任何賣空或任何購買、出售或授予任何權利(包括,不包括 對下列簽署人的任何證券或任何證券的限制(任何看跌期權或看漲期權),包括: 與此類下籤人的證券有關或從其價值的任何重要部分中獲取。

 

此外,簽字人 同意在鎖定期內未經代表事先書面同意,不會就註冊任何股份或任何可轉換爲股份的證券,或行使、要求任何權利,除非符合與發行相關的註冊聲明中所述內容。

 

鎖定期是指從本鎖定協議簽署之日起,持續至幷包括最終招股說明書日期後的180天。此招股說明書用於根據承銷協議出售股票。

 

 

 

 

儘管有前述規定 但不適用於:(i) 根據公司的任何股票激勵計劃或股票購買計劃行使(包括無現金行使或經紀人協助行使以及稅務義務支付)、歸屬或結算期權或warrants以購買股份或其他股權獎勵;前提是,任何在此類行使、轉換或交易中獲得的股份將受到鎖定期的限制,(b) 根據《交易法》第10b5-1條建立的交易計劃,用於轉讓股份(“交易計劃”);前提是:(i) 交易計劃不得規定或允許在鎖定期內進行任何轉讓、銷售或其他處置股份,並且(ii) 交易計劃不要求根據《交易法》第16(a)條進行任何申報,並且不會自願進行此類申報,(c) 在本次發行結束後通過公開市場交易獲得的股份的任何轉讓,前提是該轉讓不要求根據《交易法》第16(a)條進行任何申報,並且不會自願進行此類申報,(d) 將個人的股份或任何可轉換爲或可行使或可交易爲普通股的安防-半導體轉讓給公司,因與個人與公司之間的僱傭關係終止或根據公司有權回購此類股份的合同安排,前提是,任何一方無需根據《交易法》進行申報,並且在個人停止爲公司提供服務後的45天內不會自願進行任何此類申報, 且在此45天后,如果個人需要根據《交易法》提交報告,報告內容涉及在鎖定期內普通股的有益持有比例減少,個人應在腳註中指明該申報與個人的僱傭關係終止有關,並且與此類轉讓相關的其他公開聲明不得自願進行(除非在鎖定期滿後提交的5號表格的申報),(e) 將未償還證券轉換爲股份,前提是,在此類轉換後獲得的任何股份應受本鎖定協議中規定的轉讓限制,或(f) 根據對公司的誠意第三方要約、合併、整合或其他類似交易,轉讓股份或任何可轉換爲或可行使或可交易爲股份的安防-半導體,前提是該交易經公司董事會的無利益相關成員的批准,且所有受此鎖定協議約束的簽字方相關證券均應繼續受此處規定的限制。

 

爲進一步落實上述內容, 公司及其轉讓代理人和登記處特此被授權拒絕進行任何股份轉讓,若該轉讓將 構成對本鎖定協議的違反或違約。

 

簽署人特此聲明 並保證簽署人擁有完全的權力和授權以簽署本鎖定協議,並且,在要求時,簽署人 將執行與本協議的執行相關的任何附加文件。所有在此授予或同意授予的權力以及簽署人的任何義務 對簽署人的繼承人、受讓人、繼承人或個人代表均有約束力。

 

簽署人理解,如果(i)公司或代表通知對方不打算繼續Offering,(ii)承銷協議未生效或承銷協議(除終止後仍然有效的條款外)在貨款支付和交付之前終止或被終止,或(iii)Offering在2024年12月31日之前未完成,簽署人應從本次Lock-Up協議的所有義務中解脫。

 

簽署人明白,代表方正在根據本限售協議進行承銷協議,並繼續進行發行。

 

本鎖定協議應 受紐約州法律的管轄,並根據其解釋。

 

是否進行發行實際取決於許多因素,包括市場條件。任何發行只會根據包銷協議進行,其條款將由各方協商確定。

 

【簽名頁面如下】

 

 

 

 

  此致,
   
   
  (姓名-請打印)
   
   
  (簽名)

 

 

 

 

附件B

 

[關於鎖定解除/豁免的新聞稿格式]

 

[    ]

[日期]

 

創始人集團有限公司,按英屬維爾京群島法律註冊的股份有限公司(“公司)今天宣佈,美國虎證券公司,在公司近期公開出售普通股的主要賬簿管理人,正[放棄][解除]一項鎖定限制, 涉及公司[某些高管或董事][一位高管或董事]持有的[___]普通股。 該[放棄][解除]將於[___]生效,普通股可於該日期或之後出售。

 

本新聞稿並不構成對在美國或任何其他禁止提供的司法管轄區內的證券的出售要約,這些證券可能不得在美國內加以提供或銷售,除非根據1933年修正版的《美國證券法》進行註冊或獲得豁免。

 

 

 

 

5.80%到期於2054 年的優先票據

 

創始人集團有限公司
官員證書

 

[●],2024

 

特此由創始人集團有限公司(以下簡稱"創始人集團")首席執行官李成志及致富金融(臨時代碼)司長施先松在此證明,根據於[●] 2024年由公司與美國虎證券公司(代表所列多家承銷商)訂立的承銷協議,各自作爲公司的官員,在公司名義下,謹代表公司,如下證明:公司), 根據於 [●] 2024年與美國虎證券公司及其他多家承銷商代表所簽署的承銷協議(以下簡稱"該協議"),本公司首席執行官及致富金融(臨時代碼)司長在此證明,各自作爲公司的官員,根據各自的職務,代表公司,並無個人責任,聲明如下: 附錄A 其上述附件(以下簡稱「協議」)承銷協議”), 特此證明,作爲公司的官員,而非個人以及不負個人責任,代表公司如下:

 

1.該官員已仔細審查了註冊聲明, 一般披露材料,任何允許的自由書寫招股說明書以及招股說明書,並且在他或她的意見以及他或她的知識的最佳範圍內, 截至2024年[●]日[●]時(“適用時間)和截至交易日期不包括任何重大事實的不實陳述,也沒有省略需要陳述的重大事實, 或對使陳述不具誤導性的必要事實進行了省略,並且一般披露材料,截止適用時間和交易日期,任何允許的自由書寫招股說明書截至其日期和交易日期, 招股說明書及其各自日期的每次修訂或補充,以及截至交易日期,不包括任何重大事實的不實陳述,也沒有省略爲了使陳述在作出時的情況下不具誤導性而必要的重大事實。

 

2. 據他所知,在註冊聲明、一般披露材料或招股說明書中所提供信息的各自日期之後,並沒有發生任何重大不利變動或涉及潛在重大不利變動的發展,無論該變動是否源於普通業務交易。

 

3. 根據合理調查,截止至交割日,公司在承銷協議中的陳述和保證在所有重要方面都是真實且正確的(除了那些被限定爲重大性的陳述和保證,它們在所有方面都應是真實和正確的,此外,還包括那些提及在特定日期存在的事實的陳述和保證,它們應在該日期上是真實和正確的),並且公司已遵守所有協議,並在交割日前或交割時滿足其應履行的所有條件。

 

4. 截止日期前,據其最佳知識和合理調查,公司未遭受任何重大損失或干擾其業務,無論是否由保險承保,也未因勞工糾紛或任何法律或政府訴訟而受損。

 

5. 根據規則和規定,註冊聲明和招股說明書中無需包含的任何前期或調整後的基本報表均未被包含。

 

6. 沒有任何止損市價單或其他訂單暫停註冊聲明或其任何部分或任何修正案的有效性,也沒有暫停或阻止使用一般披露文件、任何允許的自由書面招股說明書和招股說明書的情況,且根據他所知,委員會或任何州或監管機構並沒有爲此目的啓動任何程序,也沒有計劃這樣做。

 

本證明文件中使用的大寫字母詞彙,但不在此處定義,應根據承銷協議所賦予的意義進行解釋。本證明文件可以以一個或多個副本執行,所有這些副本應被視爲同一份文件。

 

[隨附簽名頁面]

 

 

 

 

鑑於本公司代表於上述日期簽署此證書。

 

 

   
  姓名: 李成芝
  頭銜: 首席執行官

 

   
  姓名: 查看暹崇
  職稱: 首席財務官

 

 

 

 

附錄D

 

創始人集團有限公司
秘書證明

 

[●],2024

 

下方簽字的李生,首席執行官,特此證明他/她是創始人集團有限公司的合法選舉、合格及在職的秘書。公司並且作爲該秘書,他/她有權以公司的名義和 behalf簽署和交付本證書。根據2024年[●]的承銷協議,由美國虎證券公司作爲附錄A中列出多個承銷商的代表,承銷協議下方簽字的進一步證明,作爲公司秘書且不承擔個人責任,代表公司列出以下事項。此處使用的首字母大寫詞彙,除非另有定義,否則應按照承銷協議中的規定理解。

 

1. 附上了如下所示的附件。 附件A 是公司董事會(“的決議的真實完整副本董事會附件是公司董事會關於承銷協議規定的公開發行的決議真實完整複印本(以下簡稱「決議」),這些決議是在公司董事會或董事會指定的任何委員會舉行的會議上或經全體董事一致書面同意通過的,所有決議已經按照正式程序通過,未經修改、修改或廢止,且仍然有效;同時這些決議是董事會或董事會指定的任何委員會進行的唯一有關承銷協議規定的公開發行的決議。

 

2. 附上了如下所示的附件。 附錄B 公司登記文件是公司的真實、正確和完整複印件,連同所有的修正案。 尚未採取任何行動進一步修訂、修改或廢除此類章程文件,該章程文件仍按照此日期附件中的形式完全有效。 在簽署協議之前,公司、股東、董事或高管未採取任何行動,即使在提交任何此類修正案或其他文件或在公司實施根據承銷協議擬定的交易之前清算或解散的考慮中。

 

3. 附上了如下所示的附件。 展示C 是公司章程及其所有修訂的真實、正確和完整的副本。沒有采取任何行動進一步修改、變更或廢除該章程,該章程在本日期的附加表格中繼續有效。

 

4. 附上了如下所示的附件。 附件D 這是一份真實完整的良好信譽證明副本,日期爲[●], 2024,由[STATE]州州務卿簽發,涉及該公司。

 

5. 下列所列之人已被合法選舉或任命擔任其姓名對應的職位,並被授權代表公司簽署承銷協議及其相關文件,以下每人姓名對面的簽名均爲其真實簽名。

 

姓名 職位 簽名
     
     

 

本證書可以在一個或多個副本中執行,所有這些副本一起被視爲同一份文件。

 

[隨附簽名頁面]

 

 

 

 

鑑於,下籤署人在上述日期首次簽署了本證書。

 

   
  姓名: [●]
  職稱: 秘書

 

本人,致富金融(臨時代碼)首席財務官 範德集團有限公司,特此證明[____]是公司合法選舉產生的,具備資格並正式擔任秘書,並且其名字上方所署名字是她真實的簽名。

 

  由:  
  姓名: 查看暹崇
  頭銜: 首席財務官

 

 

 

 

附錄 E

 

創始人集團有限公司
首席財務官證明

 

[●],2024

 

以下籤署人,[____],特此 證明他是創始集團有限公司(以下簡稱“公司)的合法選舉、合格且在職的首席財務官,作爲該職位,他有權代表公司以公司的名義簽署並交付本證書。根據與美國老虎證券公司(作爲附錄A中列出的各承銷商的代表)簽署的承銷協議,該協議日期爲[●],2024年,簽署人進一步證明,單獨以公司的董事身份,代表公司按照下面所述的方式進行。承銷協議的法律地位。

 

1. 我作爲公司的首席財務官,已於今日正式被任命爲該職位。

 

2. 本人提供此證書,以配合註冊聲明和招股說明書中描述的證券發行。

 

3. 我熟悉公司的會計、運營、記錄系統和內部控制,並參與了註冊聲明和招股說明書的準備。

 

4. 公司的基本報表在註冊申明和招股說明書中呈現了公司及其合併子公司的財務狀況和經營成果,在所有重大方面展現了合理性。

 

5. 我已審核註冊聲明和招股說明書中的披露內容、註冊聲明中的財務和運營信息,並且根據我所知,這些信息在所有重要方面是正確、完整和準確的。

 

本證書中使用但未在此處定義的大寫字母,應具有承銷協議所賦予的含義。

 

[隨附簽名頁面]

 

 

 

 

鑑於,下籤署人在上述日期首次簽署了本證書。

 

  創始人集團有限公司
   
  由:  
  姓名:  查看暹崇
  頭銜: 首席財務官